⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.

Sources

Every dose, warning and note in Doz is cited to a specific source with a section or page. Sources are official FDA labels on DailyMed, published guidelines and (once licensed) the medical school's licensed reference. Anything that cannot be verified is not entered.

FDA label (DailyMed)

FDA Amoxicillin — Amoxicillin tablets, for oral suspension, chewable tablets and capsules — Prescribing Information (SPL effective 2026-10-06, version 4)↗[Public]
FDA Augmentin — AUGMENTIN (amoxicillin/clavulanate potassium) tablets, powder for oral suspension and chewable tablets — Prescribing Information (SPL effective 2016-09-01, version 6)↗[Public]
FDA Augmentin ES-600 — AUGMENTIN ES-600 (amoxicillin/clavulanate potassium) for oral suspension — Prescribing Information (SPL effective 2026-07-07, version 6)↗[Public]
FDA Zithromax — ZITHROMAX (azithromycin) tablets and oral suspension — Prescribing Information (SPL effective 2026-07-24, version 49)↗[Public]
FDA Risperdal — RISPERDAL (risperidone) tablets, oral solution and M-TAB orally disintegrating tablets — Prescribing Information (SPL effective 2026-05-28, version 45)↗[Public]
FDA Lactulose — Lactulose Solution USP (10 g/15 mL), Rx — Prescribing Information (SPL effective 2026-08-17, version 1)↗[Public]
FDA Ibuprofen Rx — Ibuprofen Oral Suspension USP 100 mg/5 mL, Rx only — Prescribing Information (SPL effective 2026-03-30, version 1)↗[Public]
FDA Ibuprofen OTC — Children's Ibuprofen Oral Suspension USP 100 mg/5 mL — Drug Facts (SPL effective 2026-07-15, version 1)↗[Public]
FDA Cetirizine OTC — Children's Cetirizine Hydrochloride Oral Solution 5 mg/5 mL — Drug Facts (SPL effective 2026-09-25, version 4)↗[Public]
FDA Guaif-Codeine OTC — Guaifenesin and Codeine Phosphate oral solution — Drug Facts (SPL effective 2026-06-02, version 5)↗[Public]
FDA Cephalexin — Cephalexin for oral suspension — Prescribing Information (SPL effective 2026-09-02, version 1)↗[Public]
FDA Cefixime — Cefixime for oral suspension and capsules — Prescribing Information (SPL effective 2025-10-14, version 14)↗[Public]
FDA Cefuroxime susp — Cefuroxime axetil for oral suspension — Prescribing Information (SPL effective 2013-08-19, version 1)↗[Public]
FDA Clarithromycin susp — Clarithromycin for oral suspension — Prescribing Information (SPL effective 2023-09-13, version 15)↗[Public]
FDA Clarithromycin tab — Clarithromycin tablets — Prescribing Information (SPL effective 2025-06-09, version 15)↗[Public]
FDA Cleocin Pediatric — CLEOCIN PEDIATRIC (clindamycin palmitate HCl) granules for oral solution — Prescribing Information (SPL effective 2026-06-01, version 35)↗[Public]
FDA Erythromycin ES — Erythromycin ethylsuccinate for oral suspension — Prescribing Information (SPL effective 2025-06-20, version 3)↗[Public]
FDA TMP-SMX susp — Sulfamethoxazole and trimethoprim oral suspension — Prescribing Information (SPL effective 2026-04-06, version 7)↗[Public]
FDA Famotidine susp — Famotidine for oral suspension 40 mg/5 mL — Prescribing Information (SPL effective 2026-08-04, version 1)↗[Public]
FDA Alinia — ALINIA (nitazoxanide) tablets and oral suspension — Prescribing Information (SPL effective 2024-03-20, version 10)↗[Public]
FDA Ondansetron — Ondansetron tablets — Prescribing Information (SPL effective 2026-10-12, version 14)↗[Public]
FDA Children's Benadryl — Children's Benadryl Allergy (diphenhydramine HCl 12.5 mg/5 mL) — Drug Facts (SPL effective 2026-09-11, version 15)↗[Public]
FDA Loratadine OTC — Children's Allergy Relief (loratadine 5 mg/5 mL oral solution) — Drug Facts (SPL effective 2026-09-04, version 4)↗[Public]
FDA Fexofenadine OTC — Fexofenadine HCl 30 mg/5 mL oral suspension — Drug Facts (SPL effective 2026-09-01, version 1)↗[Public]
FDA Hydroxyzine — Hydroxyzine hydrochloride tablets — Prescribing Information (SPL effective 2026-10-09, version 1)↗[Public]
FDA Desloratadine — Desloratadine tablets 5 mg — Prescribing Information (SPL effective 2026-04-16, version 12)↗[Public]
FDA Children's Tylenol — Children's Tylenol (acetaminophen 160 mg/5 mL oral suspension) — Drug Facts (SPL effective 2026-06-12, version 3)↗[Public]
FDA Mefenamic acid — Mefenamic acid capsules 250 mg — Prescribing Information (SPL effective 2026-04-20, version 13)↗[Public]
FDA Theophylline sol — Theophylline Oral Solution 80 mg/15 mL — Prescribing Information (SPL effective 2026-02-06, version 4)↗[Public]
FDA Nystatin susp — Nystatin Oral Suspension 100,000 units/mL — Prescribing Information (SPL effective 2026-10-09, version 4)↗[Public]
FDA Metronidazole — Metronidazole tablets — Prescribing Information (SPL effective 2026-09-10, version 10)↗[Public]
FDA Dicyclomine — Dicyclomine hydrochloride tablets — Prescribing Information (SPL effective 2026-10-13, version 1)↗[Public]
FDA Oseltamivir susp — Oseltamivir phosphate for oral suspension 6 mg/mL — Prescribing Information (SPL effective 2026-10-06, version 14)↗[Public]
FDA Emverm — EMVERM (mebendazole) chewable tablet 100 mg — Prescribing Information (SPL effective 2021-08-23, version 11)↗[Public]
FDA Albenza — ALBENZA (albendazole) tablets — Prescribing Information (SPL effective 2019-09-23, version 14)↗[Public]
FDA Acyclovir susp — Acyclovir Oral Suspension 200 mg/5 mL — Prescribing Information (SPL effective 2026-01-23, version 4)↗[Public]
FDA Montelukast — Montelukast sodium tablets, chewable tablets and oral granules — Prescribing Information (SPL effective 2026-07-28, version 24)↗[Public]
FDA Ventolin HFA — VENTOLIN HFA (albuterol sulfate) inhalation aerosol — Prescribing Information (SPL effective 2026-09-24, version 15)↗[Public]
FDA Permethrin 5% — Permethrin cream 5% — Prescribing Information (SPL effective 2026-07-24, version 3)↗[Public]
FDA Prednisolone sol — Prednisolone sodium phosphate oral solution 25 mg/5 mL — Prescribing Information (SPL effective 2025-12-03, version 8)↗[Public]
FDA Dexa Intensol — Dexamethasone Oral Solution USP Intensol (concentrate) 1 mg/mL — Prescribing Information (SPL effective 2026-08-21, version 1)↗[Public]
FDA Delsym — DELSYM (dextromethorphan polistirex) extended-release suspension — Drug Facts (SPL effective 2026-09-09, version 15)↗[Public]
FDA Children's Sudafed — Children's Sudafed Nasal Decongestant (pseudoephedrine HCl 15 mg/5 mL) — Drug Facts (SPL effective 2024-11-08, version 9)↗[Public]
FDA Guaifenesin OTC — Max Tussin Mucus and Chest Congestion (guaifenesin 200 mg/10 mL) — Drug Facts (SPL effective 2026-08-31, version 5)↗[Public]
FDA Omeprazole — Omeprazole delayed-release capsules — Prescribing Information (SPL effective 2026-09-01, version 1)↗[Public]
FDA Protonix — PROTONIX (pantoprazole) delayed-release tablets and oral suspension — Prescribing Information (SPL effective 2026-05-18, version 48)↗[Public]
FDA Metformin — Metformin hydrochloride tablets — Prescribing Information (SPL effective 2026-10-09, version 1)↗[Public]
FDA Atorvastatin — Atorvastatin calcium tablets — Prescribing Information (SPL effective 2026-10-08, version 4)↗[Public]
FDA Losartan — Losartan potassium tablets — Prescribing Information (SPL effective 2026-09-29, version 17)↗[Public]
FDA Amlodipine — Amlodipine besylate tablets — Prescribing Information (SPL effective 2026-10-09, version 18)↗[Public]
FDA Levothyroxine — Levothyroxine sodium tablets — Prescribing Information (SPL effective 2026-10-12, version 1)↗[Public]
FDA Diclofenac DR — Diclofenac sodium delayed-release tablets — Prescribing Information (SPL effective 2026-09-24, version 1)↗[Public]
FDA Ritalin — RITALIN (methylphenidate HCl) tablets — Prescribing Information (SPL effective 2025-02-05, version 3)↗[Public]
FDA Sertraline — Sertraline hydrochloride tablets — Prescribing Information (SPL effective 2026-09-17, version 10)↗[Public]
FDA Fluoxetine — Fluoxetine capsules — Prescribing Information (SPL effective 2026-10-02, version 1)↗[Public]
FDA Celexa — CELEXA (citalopram) tablets — Prescribing Information (SPL effective 2023-10-09, version 40)↗[Public]
FDA Aripiprazole — Aripiprazole tablets — Prescribing Information (SPL effective 2026-10-05, version 6)↗[Public]
FDA Divalproex — Divalproex sodium delayed-release tablets — Prescribing Information (SPL effective 2026-10-07, version 1)↗[Public]
FDA Lithium — Lithium carbonate tablets and capsules — Prescribing Information (SPL effective 2026-08-16, version 3)↗[Public]
FDA Lexapro — LEXAPRO (escitalopram) tablets — Prescribing Information (SPL effective 2023-10-01, version 45)↗[Public]
FDA Escitalopram — Escitalopram tablets — Prescribing Information (SPL effective 2026-10-09, version 1)↗[Public]
FDA Quetiapine — Quetiapine tablets — Prescribing Information (SPL effective 2026-09-17, version 9)↗[Public]
FDA Zyprexa — ZYPREXA (olanzapine) tablets — Prescribing Information (SPL effective 2026-10-06, version 69)↗[Public]
FDA Clonazepam — Clonazepam tablets — Prescribing Information (SPL effective 2026-10-06, version 1)↗[Public]
FDA Xanax — XANAX (alprazolam) tablets — Prescribing Information (SPL effective 2024-04-15, version 5)↗[Public]
FDA Atomoxetine — Atomoxetine capsules — Prescribing Information (SPL effective 2026-09-29, version 9)↗[Public]
FDA Carbamazepine — Carbamazepine tablets — Prescribing Information (SPL effective 2026-10-12, version 1)↗[Public]
FDA Bupropion XL — Bupropion hydrochloride extended-release tablets (XL) — Prescribing Information (SPL effective 2026-07-16, version 42)↗[Public]
FDA Venlafaxine XR — Venlafaxine hydrochloride extended-release capsules — Prescribing Information (SPL effective 2026-10-05, version 2)↗[Public]
FDA Mirtazapine — Mirtazapine tablets — Prescribing Information (SPL effective 2026-10-06, version 13)↗[Public]
FDA Trazodone — Trazodone hydrochloride tablets — Prescribing Information (SPL effective 2026-10-12, version 4)↗[Public]
FDA Buspirone — Buspirone hydrochloride tablets — Prescribing Information (SPL effective 2026-10-10, version 1)↗[Public]
FDA Haloperidol — Haloperidol tablets — Prescribing Information (SPL effective 2026-09-02, version 3)↗[Public]
FDA Rizatriptan ODT — Rizatriptan benzoate orally disintegrating tablets — Prescribing Information (SPL effective 2026-10-09, version 14)↗[Public]
FDA Sumatriptan — Sumatriptan tablets — Prescribing Information (SPL effective 2026-10-09, version 1)↗[Public]
FDA Topiramate — Topiramate tablets — Prescribing Information (SPL effective 2026-10-13, version 17)↗[Public]
FDA Propranolol — Propranolol hydrochloride tablets — Prescribing Information (SPL effective 2026-10-09, version 8)↗[Public]
FDA Tobramycin eye — Tobramycin ophthalmic solution USP 0.3% — Prescribing Information (SPL effective 2024-06-14, version 1)↗[Public]
FDA Cipro eye drops — Ciprofloxacin ophthalmic solution 0.3% — Prescribing Information (SPL effective 2026-05-05, version 2)↗[Public]
FDA Erythromycin eye — Erythromycin ophthalmic ointment USP 0.5% — Prescribing Information (SPL effective 2026-08-28, version 12)↗[Public]
FDA Pataday (OTC) — Pataday Twice Daily Relief (olopatadine 0.1%) — Drug Facts (SPL effective 2026-01-20, version 6)↗[Public]
FDA Ketotifen eye (OTC) — Ketotifen fumarate ophthalmic solution 0.025% — Drug Facts (SPL effective 2026-04-15, version 1)↗[Public]
FDA Enalapril — Enalapril maleate tablets USP — Prescribing Information (SPL effective 2026-09-16, version 3)↗[Public]
FDA Captopril — Captopril tablets USP — Prescribing Information (SPL effective 2026-09-14, version 4)↗[Public]
FDA Valsartan — Valsartan tablets USP — Prescribing Information (SPL effective 2026-08-25, version 23)↗[Public]
FDA Metoprolol tartrate — Metoprolol tartrate tablets USP — Prescribing Information (SPL effective 2026-09-29, version 1)↗[Public]
FDA Atenolol — Atenolol tablets USP — Prescribing Information (SPL effective 2026-09-28, version 13)↗[Public]
FDA Carvedilol — Carvedilol tablets — Prescribing Information (SPL effective 2026-10-06, version 8)↗[Public]
FDA Hydrochlorothiazide — Hydrochlorothiazide tablets USP — Prescribing Information (SPL effective 2026-10-12, version 5)↗[Public]
FDA Furosemide tabs — Furosemide tablets USP — Prescribing Information (SPL effective 2026-06-18, version 4)↗[Public]
FDA Furosemide solution — Furosemide oral solution USP 10 mg/mL — Prescribing Information (SPL effective 2026-06-23, version 1)↗[Public]
FDA Spironolactone — Spironolactone tablets USP — Prescribing Information (SPL effective 2026-10-07, version 10)↗[Public]
FDA Simvastatin — Simvastatin tablets USP — Prescribing Information (SPL effective 2026-08-31, version 4)↗[Public]
FDA Rosuvastatin — Rosuvastatin calcium tablets — Prescribing Information (SPL effective 2026-10-06, version 9)↗[Public]
FDA Crestor — Crestor (rosuvastatin) tablets — Prescribing Information (SPL effective 2026-09-23, version 19)↗[Public]
FDA Clopidogrel — Clopidogrel tablets USP — Prescribing Information (SPL effective 2026-09-29, version 8)↗[Public]
FDA Warfarin — Warfarin sodium tablets USP — Prescribing Information (SPL effective 2026-10-06, version 6)↗[Public]
FDA Isosorbide dinitrate — Isosorbide dinitrate tablets USP — Prescribing Information (SPL effective 2026-07-31, version 18)↗[Public]
FDA Digoxin — Digoxin tablets USP — Prescribing Information (SPL effective 2026-01-13, version 20)↗[Public]
FDA Nitroglycerin SL — Nitroglycerin sublingual tablets USP — Prescribing Information (SPL effective 2026-09-03, version 5)↗[Public]
FDA Aspirin 81 (OTC) — Aspirin 81 mg chewable tablets — Drug Facts (SPL effective 2026-10-06, version 2)↗[Public]
FDA Glyburide — Glyburide (glibenclamide) tablets USP — Prescribing Information (SPL effective 2015-05-01, version 19)↗[Public]
FDA Glimepiride — Glimepiride tablets USP — Prescribing Information (SPL effective 2026-09-24, version 1)↗[Public]
FDA Glipizide — Glipizide tablets USP — Prescribing Information (SPL effective 2026-10-13, version 17)↗[Public]
FDA Sitagliptin — Sitagliptin tablets — Prescribing Information (SPL effective 2026-09-16, version 3)↗[Public]
FDA Jardiance — Jardiance (empagliflozin) tablets — Prescribing Information (SPL effective 2026-08-26, version 1)↗[Public]
FDA Pioglitazone — Pioglitazone tablets USP — Prescribing Information (SPL effective 2025-03-05, version 1)↗[Public]
FDA Pioglitazone (2) — Pioglitazone tablets — Prescribing Information (SPL effective 2026-09-15, version 2)↗[Public]
FDA Methimazole — Methimazole tablets USP — Prescribing Information (SPL effective 2026-08-20, version 2)↗[Public]
FDA Propylthiouracil — Propylthiouracil tablets USP — Prescribing Information (SPL effective 2026-08-25, version 18)↗[Public]
FDA Humulin R — Humulin R (insulin human) U-100 injection — Prescribing Information (SPL effective 2026-06-16, version 35)↗[Public]
FDA Macrobid — Macrobid (nitrofurantoin monohydrate/macrocrystals) capsules — Prescribing Information (SPL effective 2025-10-14, version 27)↗[Public]
FDA Nitrofurantoin macro — Nitrofurantoin capsules USP (macrocrystals) — Prescribing Information (SPL effective 2026-04-23, version 5)↗[Public]
FDA Nitrofurantoin susp — Nitrofurantoin oral suspension 25 mg/5 mL — Prescribing Information (SPL effective 2025-11-11, version 5)↗[Public]
FDA Ciprofloxacin — Ciprofloxacin tablets USP — Prescribing Information (SPL effective 2026-10-08, version 5)↗[Public]
FDA Levofloxacin — Levofloxacin tablets USP — Prescribing Information (SPL effective 2026-08-21, version 7)↗[Public]
FDA Doxycycline — Doxycycline hyclate tablets USP — Prescribing Information (SPL effective 2026-10-06, version 2)↗[Public]
FDA Ceftriaxone — Ceftriaxone for injection USP — Prescribing Information (SPL effective 2026-09-30, version 18)↗[Public]
FDA Bicillin L-A — Bicillin L-A (penicillin G benzathine injectable suspension) — Prescribing Information (SPL effective 2026-07-21, version 35)↗[Public]
FDA Diflucan — Diflucan (fluconazole) tablets and oral suspension — Prescribing Information (SPL effective 2026-04-02, version 57)↗[Public]
FDA Terbinafine — Terbinafine tablets — Prescribing Information (SPL effective 2026-07-09, version 7)↗[Public]
FDA Valacyclovir — Valacyclovir tablets USP — Prescribing Information (SPL effective 2026-09-10, version 3)↗[Public]
FDA Valacyclovir 1 g — Valacyclovir hydrochloride tablets (500 mg, 1 g) — Prescribing Information (SPL effective 2026-08-13, version 6)↗[Public]
FDA Cefdinir susp — Cefdinir for oral suspension USP — Prescribing Information (SPL effective 2026-10-09, version 1)↗[Public]
FDA Naproxen — Naproxen tablets USP — Prescribing Information (SPL effective 2026-10-08, version 12)↗[Public]
FDA Celecoxib — Celecoxib capsules — Prescribing Information (SPL effective 2025-04-01, version 22)↗[Public]
FDA Meloxicam — Meloxicam tablets USP — Prescribing Information (SPL effective 2026-10-02, version 2)↗[Public]
FDA Tramadol — Tramadol hydrochloride tablets USP — Prescribing Information (SPL effective 2026-10-12, version 5)↗[Public]
FDA Methocarbamol — Methocarbamol tablets USP — Prescribing Information (SPL effective 2026-10-07, version 7)↗[Public]
FDA Baclofen — Baclofen tablets USP — Prescribing Information (SPL effective 2026-08-24, version 24)↗[Public]
FDA Baclofen (2) — Baclofen tablets USP 20 mg — Prescribing Information (SPL effective 2026-10-09, version 4)↗[Public]
FDA Colcrys — Colcrys (colchicine) tablets — Prescribing Information (SPL effective 2022-10-01, version 4)↗[Public]
FDA Allopurinol — Allopurinol tablets — Prescribing Information (SPL effective 2026-10-09, version 1)↗[Public]
FDA Amitriptyline — Amitriptyline hydrochloride tablets USP — Prescribing Information (SPL effective 2026-09-08, version 10)↗[Public]
FDA Nortriptyline — Nortriptyline hydrochloride capsules USP — Prescribing Information (SPL effective 2026-09-28, version 2)↗[Public]
FDA Neurontin — Neurontin (gabapentin) capsules, tablets, oral solution — Prescribing Information (SPL effective 2026-05-12, version 48)↗[Public]
FDA Gabapentin — Gabapentin capsules USP — Prescribing Information (SPL effective 2026-10-08, version 2)↗[Public]
FDA Lyrica — Lyrica (pregabalin) capsules and oral solution — Prescribing Information (SPL effective 2025-04-15, version 18)↗[Public]
FDA Pregabalin — Pregabalin capsules — Prescribing Information (SPL effective 2026-09-30, version 13)↗[Public]
FDA Lamotrigine — Lamotrigine tablets / ODT — Prescribing Information (SPL effective 2026-09-24, version 8)↗[Public]
FDA Levetiracetam tabs — Levetiracetam tablets USP — Prescribing Information (SPL effective 2026-09-11, version 1)↗[Public]
FDA Levetiracetam sol — Levetiracetam oral solution 100 mg/mL — Prescribing Information (SPL effective 2026-09-22, version 27)↗[Public]
FDA Phenytoin ER — Extended phenytoin sodium capsules USP — Prescribing Information (SPL effective 2026-08-20, version 2)↗[Public]
FDA Phenytoin susp — Phenytoin oral suspension 125 mg/5 mL — Prescribing Information (SPL effective 2025-08-19, version 17)↗[Public]
FDA Diazepam — Diazepam tablets USP — Prescribing Information (SPL effective 2023-04-04, version 17)↗[Public]
FDA Lorazepam — Lorazepam tablets USP — Prescribing Information (SPL effective 2026-09-30, version 17)↗[Public]
FDA Zolpidem — Zolpidem tartrate tablets — Prescribing Information (SPL effective 2026-09-01, version 27)↗[Public]
FDA Promethazine — Promethazine hydrochloride tablets USP — Prescribing Information (SPL effective 2026-09-10, version 4)↗[Public]
FDA Dimenhydrinate (OTC) — Dimenhydrinate 50 mg tablets — Drug Facts (SPL effective 2026-09-30, version 13)↗[Public]
FDA Meclizine (OTC) — Meclizine HCl 25 mg tablets — Drug Facts (SPL effective 2026-10-05, version 2)↗[Public]
FDA Loperamide (OTC) — Loperamide HCl 2 mg caplets — Drug Facts (SPL effective 2026-10-01, version 10)↗[Public]
FDA Bisacodyl (OTC) — Bisacodyl 5 mg tablets — Drug Facts (SPL effective 2026-09-18, version 1)↗[Public]
FDA Simethicone drops — Infants' gas relief drops (simethicone 20 mg/0.3 mL) — Drug Facts (SPL effective 2026-10-01, version 8)↗[Public]
FDA Simethicone 125 — Simethicone 125 mg softgels — Drug Facts (SPL effective 2026-10-08, version 5)↗[Public]
FDA Fluticasone nasal — Fluticasone propionate nasal spray USP 50 mcg — Prescribing Information (SPL effective 2026-09-24, version 12)↗[Public]
FDA Atrovent HFA — Atrovent HFA (ipratropium bromide) inhalation aerosol — Prescribing Information (SPL effective 2025-11-05, version 21)↗[Public]
FDA Tamsulosin — Tamsulosin hydrochloride capsules — Prescribing Information (SPL effective 2026-09-01, version 4)↗[Public]
FDA Oxybutynin — Oxybutynin chloride tablets USP — Prescribing Information (SPL effective 2026-07-21, version 2)↗[Public]
FDA Hydrocortisone 1% — Hydrocortisone 1% anti-itch cream — Drug Facts (SPL effective 2026-10-08, version 5)↗[Public]
FDA Betamethasone val. — Betamethasone valerate ointment USP 0.1% — Prescribing Information (SPL effective 2026-03-19, version 5)↗[Public]
FDA Mupirocin — Mupirocin ointment USP 2% — Prescribing Information (SPL effective 2026-08-20, version 4)↗[Public]
FDA Ketoconazole cream — Ketoconazole cream 2% — Prescribing Information (SPL effective 2026-09-18, version 6)↗[Public]
FDA Silver sulfadiazine — Silver sulfadiazine cream USP 1% — Prescribing Information (SPL effective 2026-07-13, version 10)↗[Public]
FDA Medroxyprogesterone — Medroxyprogesterone acetate tablets USP — Prescribing Information (SPL effective 2026-09-25, version 7)↗[Public]
FDA Lisinopril — Lisinopril tablets USP — Prescribing Information (SPL effective 2026-10-07, version 12)↗[Public]
FDA Ramipril — Ramipril capsules USP — Prescribing Information (SPL effective 2026-09-18, version 19)↗[Public]
FDA Irbesartan — Irbesartan tablets USP — Prescribing Information (SPL effective 2026-08-06, version 13)↗[Public]
FDA Telmisartan — Telmisartan tablets USP — Prescribing Information (SPL effective 2026-05-29, version 3)↗[Public]
FDA Bisoprolol — Bisoprolol fumarate tablets USP — Prescribing Information (SPL effective 2025-11-12, version 3)↗[Public]
FDA Procardia XL — Procardia XL (nifedipine) extended-release tablets — Prescribing Information (SPL effective 2026-09-21, version 20)↗[Public]
FDA Diltiazem — Diltiazem hydrochloride tablets USP — Prescribing Information (SPL effective 2025-05-05, version 1)↗[Public]
FDA Hydralazine — Hydralazine hydrochloride tablets USP — Prescribing Information (SPL effective 2026-02-02, version 13)↗[Public]
FDA Chlorthalidone — Chlorthalidone tablets USP — Prescribing Information (SPL effective 2026-09-21, version 2)↗[Public]
FDA Ezetimibe — Ezetimibe tablets USP — Prescribing Information (SPL effective 2026-01-13, version 6)↗[Public]
FDA Fenofibrate — Fenofibrate tablets 54/160 mg — Prescribing Information (SPL effective 2026-09-29, version 9)↗[Public]
FDA Eliquis — Eliquis (apixaban) tablets — Prescribing Information (SPL effective 2025-04-17, version 30)↗[Public]
FDA Xarelto — Xarelto (rivaroxaban) tablets — Prescribing Information (SPL effective 2026-09-10, version 65)↗[Public]
FDA Farxiga — Farxiga (dapagliflozin) tablets — Prescribing Information (SPL effective 2026-06-03, version 49)↗[Public]
FDA Alendronate — Alendronate sodium tablets USP — Prescribing Information (SPL effective 2026-06-12, version 17)↗[Public]
FDA Lantus — Lantus (insulin glargine) injection — Prescribing Information (SPL effective 2025-06-02, version 35)↗[Public]
FDA Penicillin VK — Penicillin V potassium tablets and oral solution — Prescribing Information (SPL effective 2023-01-31, version 15)↗[Public]
FDA Cefadroxil caps — Cefadroxil capsules USP — Prescribing Information (SPL effective 2025-10-10, version 8)↗[Public]
FDA Cefadroxil susp — Cefadroxil for oral suspension USP — Prescribing Information (SPL effective 2025-10-08, version 9)↗[Public]
FDA Fosfomycin — Fosfomycin tromethamine granules for oral solution — Prescribing Information (SPL effective 2026-09-10, version 2)↗[Public]
FDA Tinidazole — Tinidazole tablets — Prescribing Information (SPL effective 2025-12-17, version 9)↗[Public]
FDA Griseofulvin susp — Griseofulvin oral suspension (microsize) — Prescribing Information (SPL effective 2023-09-30, version 17)↗[Public]
FDA Itraconazole — Itraconazole capsules — Prescribing Information (SPL effective 2026-09-17, version 27)↗[Public]
FDA Ivermectin — Ivermectin tablets USP 3 mg — Prescribing Information (SPL effective 2024-08-28, version 3)↗[Public]
FDA Biltricide — Biltricide (praziquantel) tablets — Prescribing Information (SPL effective 2026-03-02, version 13)↗[Public]
FDA Pyrantel (OTC) — Pinworm medicine (pyrantel pamoate) chewable tablets — Drug Facts (SPL effective 2026-07-27, version 1)↗[Public]
FDA Famciclovir — Famciclovir tablets — Prescribing Information (SPL effective 2026-07-21, version 1)↗[Public]
FDA Ofloxacin otic — Ofloxacin otic solution 0.3% — Prescribing Information (SPL effective 2026-09-15, version 10)↗[Public]
FDA Nexium — Nexium (esomeprazole magnesium) delayed-release capsules — Prescribing Information (SPL effective 2025-12-19, version 74)↗[Public]
FDA Lansoprazole — Lansoprazole delayed-release capsules — Prescribing Information (SPL effective 2022-03-01, version 26)↗[Public]
FDA Pepto-Bismol (OTC) — Pepto-Bismol (bismuth subsalicylate 525 mg/30 mL) — Drug Facts (SPL effective 2026-10-06, version 19)↗[Public]
FDA Senna (OTC) — Senna laxative (sennosides 8.6 mg) tablets — Drug Facts (SPL effective 2026-09-29, version 8)↗[Public]
FDA Docusate (OTC) — Docusate sodium 100 mg softgels — Drug Facts (SPL effective 2026-10-07, version 2)↗[Public]
FDA Metamucil (OTC) — Metamucil (psyllium husk) powder — Drug Facts (SPL effective 2026-10-02, version 22)↗[Public]
FDA Prochlorperazine — Prochlorperazine maleate tablets — Prescribing Information (SPL effective 2026-10-05, version 2)↗[Public]
FDA Advair Diskus — Advair Diskus (fluticasone propionate/salmeterol) — Prescribing Information (SPL effective 2026-03-26, version 32)↗[Public]
FDA Spiriva Respimat — Spiriva Respimat (tiotropium) inhalation spray — Prescribing Information (SPL effective 2026-08-17, version 16)↗[Public]
FDA QVAR RediHaler — QVAR RediHaler (beclomethasone dipropionate HFA) — Prescribing Information (SPL effective 2025-09-30, version 17)↗[Public]
FDA Mometasone nasal — Mometasone furoate nasal spray 50 mcg (OTC) — Drug Facts (SPL effective 2026-03-06, version 5)↗[Public]
FDA Azelastine nasal — Azelastine HCl nasal spray 205.5 mcg (OTC) — Drug Facts (SPL effective 2026-10-02, version 7)↗[Public]
FDA Oxymetazoline (OTC) — Oxymetazoline HCl 0.05% nasal spray — Drug Facts (SPL effective 2026-10-01, version 4)↗[Public]
FDA Benzonatate — Benzonatate capsules USP — Prescribing Information (SPL effective 2026-09-16, version 1)↗[Public]
FDA Prednisone — Prednisone tablets USP — Prescribing Information (SPL effective 2026-09-15, version 10)↗[Public]
FDA Medrol — Medrol (methylprednisolone) tablets — Prescribing Information (SPL effective 2025-11-14, version 25)↗[Public]
FDA Paroxetine — Paroxetine tablets USP — Prescribing Information (SPL effective 2026-08-21, version 1)↗[Public]
FDA Duloxetine — Duloxetine delayed-release capsules — Prescribing Information (SPL effective 2025-12-21, version 12)↗[Public]
FDA Fluvoxamine — Fluvoxamine maleate tablets — Prescribing Information (SPL effective 2026-09-11, version 16)↗[Public]
FDA Clomipramine — Clomipramine hydrochloride capsules USP — Prescribing Information (SPL effective 2025-12-26, version 10)↗[Public]
FDA Imipramine — Imipramine hydrochloride tablets USP — Prescribing Information (SPL effective 2026-08-11, version 21)↗[Public]
FDA Oxcarbazepine — Oxcarbazepine tablets — Prescribing Information (SPL effective 2026-08-26, version 1)↗[Public]
FDA Cyclobenzaprine — Cyclobenzaprine hydrochloride tablets USP — Prescribing Information (SPL effective 2026-09-05, version 1)↗[Public]
FDA Tizanidine — Tizanidine tablets — Prescribing Information (SPL effective 2026-09-18, version 15)↗[Public]
FDA Ropinirole — Ropinirole tablets — Prescribing Information (SPL effective 2026-09-02, version 22)↗[Public]
FDA Aricept — Aricept (donepezil hydrochloride) tablets — Prescribing Information (SPL effective 2021-12-30, version 33)↗[Public]
FDA Memantine — Memantine hydrochloride tablets USP — Prescribing Information (SPL effective 2025-06-23, version 2)↗[Public]
FDA Carbidopa-levodopa — Carbidopa and levodopa tablets USP — Prescribing Information (SPL effective 2026-07-09, version 21)↗[Public]
FDA Varenicline — Varenicline tablets — Prescribing Information (SPL effective 2026-09-21, version 4)↗[Public]
FDA Nicotine patch (OTC) — Nicotine transdermal system 21/14/7 mg — Drug Facts (SPL effective 2026-09-10, version 12)↗[Public]
FDA Nicotine gum (OTC) — Nicotine polacrilex gum 2/4 mg — Drug Facts (SPL effective 2026-10-02, version 2)↗[Public]
FDA Prazosin — Prazosin hydrochloride capsules USP — Prescribing Information (SPL effective 2026-10-08, version 5)↗[Public]
FDA Clonidine — Clonidine hydrochloride tablets USP — Prescribing Information (SPL effective 2026-09-30, version 5)↗[Public]
FDA Finasteride — Finasteride tablets 5 mg — Prescribing Information (SPL effective 2026-09-17, version 10)↗[Public]
FDA Sildenafil — Sildenafil citrate tablets — Prescribing Information (SPL effective 2026-05-13, version 4)↗[Public]
FDA Tadalafil — Tadalafil tablets — Prescribing Information (SPL effective 2025-03-01, version 9)↗[Public]
FDA Solifenacin — Solifenacin succinate tablets — Prescribing Information (SPL effective 2026-09-22, version 2)↗[Public]
FDA Tolterodine — Tolterodine tartrate tablets — Prescribing Information (SPL effective 2025-04-01, version 3)↗[Public]
FDA Phenazopyridine — Phenazopyridine HCl 99.5 mg urinary pain relief — Drug Facts (SPL effective 2026-10-06, version 1)↗[Public]
FDA Plan B One-Step — Plan B One-Step (levonorgestrel 1.5 mg) — Drug Facts (SPL effective 2023-01-31, version 5)↗[Public]
FDA Norethindrone — Norethindrone acetate tablets USP 5 mg — Prescribing Information (SPL effective 2026-01-29, version 10)↗[Public]
FDA Tranexamic acid — Tranexamic acid tablets 650 mg — Prescribing Information (SPL effective 2026-05-13, version 1)↗[Public]
FDA MetroGel vaginal — Metronidazole vaginal gel 0.75% — Prescribing Information (SPL effective 2026-10-01, version 1)↗[Public]
FDA Monistat 3 (OTC) — Monistat 3 (miconazole nitrate 200 mg) — Drug Facts (SPL effective 2026-09-24, version 4)↗[Public]
FDA Clomiphene — Clomiphene citrate tablets USP 50 mg — Prescribing Information (SPL effective 2026-07-16, version 1)↗[Public]
FDA Adapalene (OTC) — Adapalene 0.1% gel — Drug Facts (SPL effective 2026-09-22, version 4)↗[Public]
FDA Benzoyl peroxide — Benzoyl peroxide 10% acne cream — Drug Facts (SPL effective 2026-10-08, version 3)↗[Public]
FDA Clindamycin gel — Clindamycin phosphate gel USP 1% — Prescribing Information (SPL effective 2025-12-02, version 5)↗[Public]
FDA Triamcinolone cream — Triamcinolone acetonide cream USP 0.1% — Prescribing Information (SPL effective 2026-07-07, version 4)↗[Public]
FDA Clobetasol cream — Clobetasol propionate cream USP 0.05% — Prescribing Information (SPL effective 2023-12-29, version 12)↗[Public]
FDA Nystatin cream — Nystatin cream USP 100,000 units/g — Prescribing Information (SPL effective 2026-05-01, version 9)↗[Public]
FDA Acyclovir cream — Acyclovir cream 5% — Prescribing Information (SPL effective 2026-06-18, version 5)↗[Public]
FDA EpiPen — EpiPen / EpiPen Jr (epinephrine) auto-injector — Prescribing Information (SPL effective 2023-02-15, version 37)↗[Public]
FDA Carbamide peroxide — Carbamide peroxide 6.5% earwax removal drops — Drug Facts (SPL effective 2026-10-05, version 3)↗[Public]
FDA Chlordiazepoxide — Chlordiazepoxide HCl capsules USP — Prescribing Information (SPL effective 2026-05-05, version 1)↗[Public]
FDA Oxazepam — Oxazepam capsules USP — Prescribing Information (SPL effective 2025-09-22, version 1)↗[Public]
FDA Trifluoperazine — Trifluoperazine HCl tablets USP — Prescribing Information (SPL effective 2025-07-22, version 11)↗[Public]
FDA Perphenazine — Perphenazine tablets USP — Prescribing Information (SPL effective 2026-08-25, version 20)↗[Public]
FDA Trihexyphenidyl — Trihexyphenidyl HCl tablets USP — Prescribing Information (SPL effective 2024-02-02, version 10)↗[Public]
FDA Clozapine — Clozapine tablets USP — Prescribing Information (SPL effective 2026-05-11, version 1)↗[Public]
FDA Geodon — Geodon (ziprasidone) capsules — Prescribing Information (SPL effective 2025-01-13, version 50)↗[Public]
FDA Valproic acid sol. — Valproic acid oral solution 250 mg/5 mL — Prescribing Information (SPL effective 2025-01-24, version 22)↗[Public]
FDA Cimetidine — Cimetidine tablets USP — Prescribing Information (SPL effective 2022-11-30, version 12)↗[Public]
FDA Mylanta (OTC) — Mylanta (calcium carbonate / magnesium hydroxide / simethicone) — Drug Facts (SPL effective 2026-08-15, version 1)↗[Public]
FDA Librax (generic) — Chlordiazepoxide HCl and clidinium bromide capsules — Prescribing Information (SPL effective 2025-09-03, version 5)↗[Public]
FDA Mesalamine DR — Mesalamine delayed-release tablets 800 mg — Prescribing Information (SPL effective 2026-07-14, version 9)↗[Public]
FDA Ursodiol — Ursodiol capsules USP 300 mg — Prescribing Information (SPL effective 2023-07-31, version 15)↗[Public]
FDA APAP-codeine — Acetaminophen and codeine phosphate tablets USP — Prescribing Information (SPL effective 2026-09-18, version 10)↗[Public]
FDA Albuterol syrup — Albuterol sulfate syrup 2 mg/5 mL — Prescribing Information (SPL effective 2025-12-17, version 1)↗[Public]
FDA Albuterol neb — Albuterol sulfate inhalation solution 0.63/1.25 mg — Prescribing Information (SPL effective 2026-04-30, version 10)↗[Public]
FDA Ampicillin — Ampicillin capsules USP — Prescribing Information (SPL effective 2025-08-14, version 4)↗[Public]
FDA Dicloxacillin — Dicloxacillin sodium capsules USP — Prescribing Information (SPL effective 2022-06-22, version 12)↗[Public]
FDA Gentamicin inj. — Gentamicin sulfate injection USP 40 mg/mL — Prescribing Information (SPL effective 2026-05-20, version 22)↗[Public]
FDA FeverAll Jr (OTC) — FeverAll Jr. Strength (acetaminophen 325 mg) suppositories — Drug Facts (SPL effective 2026-09-03, version 8)↗[Public]
FDA Fe-Vite drops — Fe-Vite iron oral solution (ferrous sulfate, 15 mg iron/mL) — supplement label (SPL effective 2026-04-10, version 6)↗[Public]
FDA Diazepam rectal gel — Diazepam rectal gel 5 mg/mL — Prescribing Information (SPL effective 2026-05-28, version 3)↗[Public]
FDA Ketorolac inj. — Ketorolac tromethamine injection — Prescribing Information (SPL effective 2026-09-29, version 3)↗[Public]
FDA Metoclopramide inj. — Metoclopramide injection 5 mg/mL — Prescribing Information (SPL effective 2026-08-19, version 1)↗[Public]
FDA Dexamethasone inj. — Dexamethasone sodium phosphate injection 4 mg/mL — Prescribing Information (SPL effective 2026-08-31, version 1)↗[Public]
FDA Solu-Cortef — Solu-Cortef (hydrocortisone sodium succinate) — Prescribing Information (SPL effective 2026-09-29, version 31)↗[Public]
FDA Promethazine inj. — Promethazine HCl injection 25 mg/mL — Prescribing Information (SPL effective 2025-12-18, version 3)↗[Public]
FDA Diazepam inj. — Diazepam injection 5 mg/mL — Prescribing Information (SPL effective 2026-08-19, version 2)↗[Public]
FDA Epinephrine 1 mg/mL — Epinephrine injection 1 mg/mL — Prescribing Information (SPL effective 2026-09-23, version 6)↗[Public]
FDA Thiamine inj. — Thiamine hydrochloride injection 100 mg/mL — Prescribing Information (SPL effective 2026-10-06, version 2)↗[Public]
FDA Levora — Levora 0.15/30 (levonorgestrel/ethinyl estradiol) — Prescribing Information (SPL effective 2025-07-24, version 10)↗[Public]
FDA Crinone — Crinone (progesterone gel) 4%/8% — Prescribing Information (SPL effective 2024-05-21, version 11)↗[Public]
FDA Cabergoline — Cabergoline tablets 0.5 mg — Prescribing Information (SPL effective 2026-06-22, version 4)↗[Public]
FDA Bromocriptine — Bromocriptine mesylate tablets/capsules — Prescribing Information (SPL effective 2026-07-27, version 4)↗[Public]
FDA Fluorometholone eye — Fluorometholone ophthalmic suspension 0.1% — Prescribing Information (SPL effective 2026-08-12, version 8)↗[Public]
FDA Artificial tears — Artificial tears (dextran/glycerin/hypromellose) — Drug Facts (SPL effective 2026-07-07, version 5)↗[Public]
FDA Ciprofloxacin otic — Ciprofloxacin otic solution 0.2% — Prescribing Information (SPL effective 2026-09-22, version 2)↗[Public]
FDA Cipro HC otic — Ciprofloxacin/hydrocortisone otic suspension — Prescribing Information (SPL effective 2026-05-29, version 1)↗[Public]
FDA Nizoral shampoo — Nizoral A-D (ketoconazole 1%) shampoo — Drug Facts (SPL effective 2026-09-10, version 8)↗[Public]
FDA Rogaine women (OTC) — Women’s Rogaine (minoxidil 5% foam) — Drug Facts (SPL effective 2024-11-13, version 6)↗[Public]
FDA Calamine lotion — Calamine lotion (calamine 8% / zinc oxide 8%) — Drug Facts (SPL effective 2026-01-29, version 3)↗[Public]
FDA Urea 20% cream — Uracin (urea 20%) cream — product label (SPL effective 2026-10-06, version 6)↗[Public]
FDA Atropine inj. — Atropine sulfate injection (Hospira) — Prescribing Information (SPL effective 2026-05-18, version 31)↗[Public]
FDA Naloxone inj. — Naloxone hydrochloride injection (Dr. Reddy's) — Prescribing Information (SPL effective 2026-01-01, version 9)↗[Public]
FDA Flumazenil inj. — Flumazenil injection 0.1 mg/mL — Prescribing Information (SPL effective 2025-12-18, version 2)↗[Public]
FDA Gvoke (glucagon) — Gvoke (glucagon injection) — Prescribing Information (SPL effective 2026-10-06, version 22)↗[Public]
FDA Dextrose 50% inj. — 50% Dextrose Injection, USP (25 g/50 mL syringe) — Prescribing Information (SPL effective 2024-02-22, version 5)↗[Public]
FDA Mag. sulfate 50% — Magnesium sulfate injection 50% (Hospira) — Prescribing Information (SPL effective 2026-04-23, version 22)↗[Public]
FDA Calcium gluconate — Calcium Gluconate in Sodium Chloride Injection — Prescribing Information (SPL effective 2026-07-31, version 4)↗[Public]
FDA Actidose (charcoal) — Actidose activated charcoal suspension — Drug Facts (SPL effective 2026-07-28, version 8)↗[Public]
FDA Xylocaine MPF — Xylocaine-MPF (lidocaine HCl) injection — Prescribing Information (SPL effective 2026-07-28, version 1)↗[Public]
FDA Xylocaine Dental — 2% Xylocaine DENTAL (lidocaine HCl and epinephrine) — Prescribing Information (SPL effective 2026-08-13, version 10)↗[Public]
FDA Diphenhydramine inj. — Diphenhydramine hydrochloride injection 50 mg/mL — Prescribing Information (SPL effective 2026-07-23, version 1)↗[Public]
FDA Phytonadione inj. — Phytonadione injectable emulsion 1 mg/0.5 mL (Dr. Reddy's) — Prescribing Information (SPL effective 2026-09-30, version 8)↗[Public]
FDA Morphine inj. — Morphine sulfate injection 4 mg/mL (Civica) — Prescribing Information (SPL effective 2026-09-01, version 5)↗[Public]
FDA Meperidine inj. — Meperidine hydrochloride injection (Hikma) — Prescribing Information (SPL effective 2024-04-09, version 11)↗[Public]
FDA Nayzilam — Nayzilam (midazolam) nasal spray 5 mg — Prescribing Information (SPL effective 2023-01-19, version 4)↗[Public]
FDA Furosemide inj. — Furosemide injection 10 mg/mL (Amneal) — Prescribing Information (SPL effective 2026-09-17, version 15)↗[Public]
FDA 0.9% NaCl (Baxter) — Sodium Chloride Injection, USP 0.9% (Viaflo) — Prescribing Information (SPL effective 2025-06-30, version 20)↗[Public]
FDA Lactated Ringer's — Lactated Ringer's Injection, USP — Prescribing Information (SPL effective 2025-10-27, version 12)↗[Public]
FDA Orabloc (articaine) — Orabloc (articaine HCl and epinephrine) dental injection — Prescribing Information (SPL effective 2026-09-22, version 3)↗[Public]
FDA Polocaine Dental — Polocaine Dental (mepivacaine HCl 3%) — Prescribing Information (SPL effective 2024-02-21, version 1)↗[Public]
FDA Anbesol Max — Anbesol Maximum Strength (benzocaine 20%) liquid — Drug Facts (SPL effective 2026-06-22, version 5)↗[Public]
FDA Chlorhexidine rinse — Chlorhexidine gluconate 0.12% oral rinse — Prescribing Information (SPL effective 2026-09-22, version 1)↗[Public]
FDA Advil Dual Action — Advil Dual Action with Acetaminophen (ibuprofen 125 mg / acetaminophen 250 mg) — Drug Facts (SPL effective 2026-07-04, version 1)↗[Public]
FDA Advil tablets — Advil (ibuprofen 200 mg) tablets — Drug Facts (SPL effective 2026-07-03, version 2)↗[Public]
FDA Aleve caplets — Aleve (naproxen sodium 220 mg) caplets — Drug Facts (SPL effective 2026-07-03, version 4)↗[Public]
FDA Vardenafil — Vardenafil hydrochloride tablets (Lannett) — Prescribing Information (SPL effective 2026-07-15, version 9)↗[Public]
FDA Stendra — Stendra (avanafil) tablets — Prescribing Information (SPL effective 2024-07-18, version 7)↗[Public]
FDA Testosterone cyp. — Testosterone cypionate injection — Prescribing Information (SPL effective 2026-09-09, version 1)↗[Public]
FDA AndroGel 1.62% — AndroGel (testosterone gel) 1.62% — Prescribing Information (SPL effective 2025-10-22, version 130)↗[Public]
FDA Addyi — Addyi (flibanserin) tablets — Prescribing Information (SPL effective 2025-12-22, version 15)↗[Public]
FDA Vyleesi — Vyleesi (bremelanotide) injection — Prescribing Information (SPL effective 2025-11-13, version 1)↗[Public]
FDA Yasmin — Yasmin (drospirenone 3 mg / ethinyl estradiol 0.03 mg) — Prescribing Information (SPL effective 2023-05-19, version 21)↗[Public]
FDA Depo-Provera CI — Depo-Provera CI (medroxyprogesterone acetate 150 mg/mL) — Prescribing Information (SPL effective 2026-08-25, version 29)↗[Public]
FDA ella — ella (ulipristal acetate 30 mg) — Prescribing Information (SPL effective 2026-07-20, version 7)↗[Public]
FDA Estrace cream — Estrace (estradiol vaginal cream 0.01%) — Prescribing Information (SPL effective 2024-05-29, version 25)↗[Public]
FDA Verapamil ER — Verapamil hydrochloride extended-release tablets (Zydus) — Prescribing Information (SPL effective 2026-04-06, version 1)↗[Public]
FDA Amiodarone tablets — Amiodarone hydrochloride tablets (Dr. Reddy's) — Prescribing Information (SPL effective 2026-04-23, version 2)↗[Public]
FDA Enoxaparin — Enoxaparin sodium injection — Prescribing Information (SPL effective 2026-10-12, version 8)↗[Public]
FDA Heparin inj. — Heparin sodium injection (Gland) — Prescribing Information (SPL effective 2026-09-09, version 13)↗[Public]
FDA Dabigatran — Dabigatran etexilate capsules (Ascend) — Prescribing Information (SPL effective 2026-08-03, version 27)↗[Public]
FDA Methyldopa — Methyldopa tablets (Rising) — Prescribing Information (SPL effective 2025-03-28, version 3)↗[Public]
FDA Labetalol — Labetalol hydrochloride tablets — Prescribing Information (SPL effective 2026-06-08, version 4)↗[Public]
FDA ISMN (Genus) — Isosorbide mononitrate tablets (Genus) — Prescribing Information (SPL effective 2026-04-09, version 1)↗[Public]
FDA Candesartan — Candesartan cilexetil tablets — Prescribing Information (SPL effective 2026-09-07, version 4)↗[Public]
FDA Perindopril — Perindopril erbumine tablets (Aurobindo) — Prescribing Information (SPL effective 2024-03-13, version 17)↗[Public]
FDA Gemfibrozil — Gemfibrozil tablets 600 mg (Northstar) — Prescribing Information (SPL effective 2026-04-10, version 25)↗[Public]
FDA Humulin N — Humulin N (human insulin isophane) — Prescribing Information (SPL effective 2025-12-19, version 50)↗[Public]
FDA NovoLog — NovoLog (insulin aspart) — Prescribing Information (SPL effective 2023-02-28, version 34)↗[Public]
FDA Tradjenta — Tradjenta (linagliptin) — Prescribing Information (SPL effective 2025-03-21, version 32)↗[Public]
FDA Acarbose — Acarbose tablets (Strides) — Prescribing Information (SPL effective 2026-07-15, version 10)↗[Public]
FDA Cortef tablets — Cortef (hydrocortisone) tablets — Prescribing Information (SPL effective 2025-02-17, version 17)↗[Public]
FDA Fludrocortisone — Fludrocortisone acetate tablets 0.1 mg — Prescribing Information (SPL effective 2026-05-13, version 4)↗[Public]
FDA Desmopressin tablets — Desmopressin acetate tablets (Apotex) — Prescribing Information (SPL effective 2026-09-10, version 10)↗[Public]
FDA Calcitriol — Calcitriol capsules 0.25 mcg (Hikma) — Prescribing Information (SPL effective 2026-07-10, version 17)↗[Public]
FDA Estradiol tablets — Estradiol tablets USP (Epic) — Prescribing Information (SPL effective 2026-02-26, version 13)↗[Public]
FDA Premarin — Premarin (conjugated estrogens) tablets — Prescribing Information (SPL effective 2026-06-04, version 37)↗[Public]
FDA Misoprostol — Misoprostol tablets (Mylan) — Prescribing Information (SPL effective 2026-08-25, version 16)↗[Public]
FDA Methylergonovine — Methylergonovine maleate tablets 0.2 mg — Prescribing Information (SPL effective 2026-10-08, version 7)↗[Public]
FDA Letrozole — Letrozole tablets 2.5 mg (Breckenridge) — Prescribing Information (SPL effective 2026-08-17, version 13)↗[Public]
FDA Diclegis — Diclegis (doxylamine 10 mg / pyridoxine 10 mg) delayed-release — Prescribing Information (SPL effective 2025-12-03, version 15)↗[Public]
FDA Cefazolin inj. — Cefazolin for injection (WG Critical Care) — Prescribing Information (SPL effective 2026-06-24, version 12)↗[Public]
FDA Cefpodoxime susp. — Cefpodoxime proxetil for oral suspension (Rising) — Prescribing Information (SPL effective 2025-06-06, version 7)↗[Public]
FDA Cefprozil susp. — Cefprozil for oral suspension (Northstar) — Prescribing Information (SPL effective 2026-07-09, version 9)↗[Public]
FDA Cefaclor caps. — Cefaclor capsules (Carlsbad) — Prescribing Information (SPL effective 2025-05-01, version 4)↗[Public]
FDA Tetracycline caps. — Tetracycline hydrochloride capsules (Breckenridge) — Prescribing Information (SPL effective 2026-05-22, version 9)↗[Public]
FDA Minocycline caps. — Minocycline hydrochloride capsules (Actavis) — Prescribing Information (SPL effective 2025-06-01, version 24)↗[Public]
FDA Moxifloxacin — Moxifloxacin hydrochloride tablets (Rising) — Prescribing Information (SPL effective 2025-10-10, version 12)↗[Public]
FDA Rifampin caps. — Rifampin capsules (ANI) — Prescribing Information (SPL effective 2024-10-10, version 1)↗[Public]
FDA Isoniazid — Isoniazid tablets (Marlex) — Prescribing Information (SPL effective 2025-09-11, version 3)↗[Public]
FDA Hydroxychloroquine — Hydroxychloroquine sulfate tablets 200 mg (Teva) — Prescribing Information (SPL effective 2024-02-29, version 6)↗[Public]
FDA Chloroquine — Chloroquine phosphate tablets (Amneal) — Prescribing Information (SPL effective 2026-09-29, version 12)↗[Public]
FDA Primaquine — Primaquine phosphate tablets (Ingenus) — Prescribing Information (SPL effective 2026-02-23, version 5)↗[Public]
FDA Cafergot — Cafergot (ergotamine tartrate 1 mg / caffeine 100 mg) tablets — Prescribing Information (SPL effective 2026-03-23, version 1)↗[Public]
FDA Pramipexole — Pramipexole dihydrochloride tablets (Strides) — Prescribing Information (SPL effective 2025-08-17, version 12)↗[Public]
FDA Amantadine caps. — Amantadine hydrochloride capsules 100 mg — Prescribing Information (SPL effective 2026-06-17, version 1)↗[Public]
FDA Rivastigmine caps. — Rivastigmine tartrate capsules (Aurobindo) — Prescribing Information (SPL effective 2024-06-19, version 9)↗[Public]
FDA Chlorpromazine — Chlorpromazine hydrochloride tablets (Northstar) — Prescribing Information (SPL effective 2026-08-26, version 7)↗[Public]
FDA Doxepin caps. — Doxepin hydrochloride capsules (Amneal) — Prescribing Information (SPL effective 2026-08-20, version 16)↗[Public]
FDA Xifaxan — Xifaxan (rifaximin) tablets — Prescribing Information (SPL effective 2025-06-25, version 50)↗[Public]
FDA Creon — Creon (pancrelipase) delayed-release capsules — Prescribing Information (SPL effective 2024-02-28, version 109)↗[Public]
FDA Glycerin suppository — Glycerin suppositories 2 g (CVS) — Drug Facts (SPL effective 2026-08-04, version 2)↗[Public]
FDA NasalCrom — NasalCrom (cromolyn sodium 5.2 mg/spray) — Drug Facts (SPL effective 2026-06-03, version 14)↗[Public]
FDA Symbicort — Symbicort (budesonide/formoterol) inhalation aerosol — Prescribing Information (SPL effective 2026-03-12, version 1)↗[Public]
FDA Acetylcysteine sol. — Acetylcysteine solution 10%/20% (Hospira) — Prescribing Information (SPL effective 2026-05-22, version 22)↗[Public]
FDA Zenatane — Zenatane (isotretinoin) capsules — Prescribing Information (SPL effective 2026-09-20, version 29)↗[Public]
FDA Azelaic acid 15% — Azelaic acid gel 15% (Encube) — Prescribing Information (SPL effective 2025-12-24, version 3)↗[Public]
FDA Tacrolimus oint. — Tacrolimus ointment 0.03%/0.1% (Glenmark) — Prescribing Information (SPL effective 2026-04-15, version 8)↗[Public]
FDA Calcipotriene cream — Calcipotriene cream 0.005% (Glenmark) — Prescribing Information (SPL effective 2026-10-07, version 8)↗[Public]
FDA Mometasone cream — Mometasone furoate cream 0.1% (Sun) — Prescribing Information (SPL effective 2025-07-07, version 6)↗[Public]
FDA Desitin Max — Desitin Maximum Strength zinc oxide 40% paste — Drug Facts (SPL effective 2025-02-28, version 5)↗[Public]
FDA Atropine 1% eye — Atropine sulfate ophthalmic solution 1% (Edenbridge) — Prescribing Information (SPL effective 2026-05-07, version 2)↗[Public]
FDA Tropicamide — Tropicamide ophthalmic solution 0.5%/1% — Prescribing Information (SPL effective 2026-09-10, version 1)↗[Public]
FDA Cyclogyl — Cyclogyl (cyclopentolate) ophthalmic solution — Prescribing Information (SPL effective 2024-06-25, version 15)↗[Public]
FDA Timolol eye — Timolol maleate ophthalmic solution 0.25%/0.5% — Prescribing Information (SPL effective 2025-12-15, version 11)↗[Public]
FDA Latanoprost — Latanoprost ophthalmic solution 0.005% — Prescribing Information (SPL effective 2026-09-08, version 4)↗[Public]
FDA Pred acetate 1% eye — Prednisolone acetate ophthalmic suspension 1% — Prescribing Information (SPL effective 2026-07-23, version 1)↗[Public]
FDA Tetracaine eye — Tetracaine hydrochloride ophthalmic solution 0.5% — Prescribing Information (SPL effective 2026-07-03, version 1)↗[Public]
FDA Gentamicin eye — Gentamicin sulfate ophthalmic solution 0.3% (Bausch & Lomb) — Prescribing Information (SPL effective 2024-07-22, version 15)↗[Public]
FDA Ofloxacin eye — Ofloxacin ophthalmic solution 0.3% (Apotex) — Prescribing Information (SPL effective 2026-09-15, version 13)↗[Public]
FDA Sklice (OTC) — Sklice (ivermectin) lotion 0.5% — Drug Facts (SPL effective 2024-07-11, version 6)↗[Public]
FDA Natroba — Natroba (spinosad 0.9%) topical suspension — Prescribing Information (SPL effective 2026-03-04, version 2)↗[Public]
FDA Levocetirizine tab — Levocetirizine dihydrochloride tablets 5 mg (Glenmark) — Prescribing Information (SPL effective 2026-09-09, version 20)↗[Public]
FDA Levocetirizine sol. — Levocetirizine dihydrochloride oral solution 2.5 mg/5 mL — Prescribing Information (SPL effective 2025-07-31, version 18)↗[Public]
FDA Epinastine eye — Epinastine HCl ophthalmic solution 0.05% — Prescribing Information (SPL effective 2025-03-22, version 7)↗[Public]
FDA Cromolyn 4% eye — Cromolyn sodium ophthalmic solution 4% (Sandoz) — Prescribing Information (SPL effective 2025-02-20, version 7)↗[Public]
FDA Azelastine eye — Azelastine hydrochloride ophthalmic solution 0.05% (Apotex) — Prescribing Information (SPL effective 2026-09-08, version 11)↗[Public]
FDA Naphazoline+phenir. — Naphazoline 0.02675% + pheniramine 0.315% eye drops (eye allergy relief) — Drug Facts (SPL effective 2026-09-28, version 4)↗[Public]
FDA Terbutaline tab — Terbutaline sulfate tablets (Upsher-Smith) — Prescribing Information (SPL effective 2025-08-27, version 4)↗[Public]
FDA Aminophylline inj. — Aminophylline injection 25 mg/mL (Hospira) — Prescribing Information (SPL effective 2026-05-22, version 29)↗[Public]
FDA Rhinocort Aqua — Rhinocort Aqua (budesonide) nasal spray 32 mcg — Prescribing Information (SPL effective 2012-02-07, version 3)↗[Public]
FDA Saline nasal 0.65% — Saline nasal spray (sodium chloride 0.65%) — Drug Facts (SPL effective 2026-10-02, version 1)↗[Public]
FDA Claritin-D 12h — Claritin-D 12 Hour (loratadine 5 mg / pseudoephedrine sulfate 120 mg) — Drug Facts (SPL effective 2025-12-05, version 10)↗[Public]
FDA Zyrtec-D — Zyrtec-D (cetirizine 5 mg / pseudoephedrine 120 mg) — Drug Facts (SPL effective 2026-04-06, version 6)↗[Public]
FDA DayQuil liquid — Vicks DayQuil Cold & Flu (acetaminophen/dextromethorphan/phenylephrine) liquid — Drug Facts (SPL effective 2026-10-05, version 4)↗[Public]
FDA NyQuil liquid — Vicks NyQuil Cold & Flu (acetaminophen/dextromethorphan/doxylamine) liquid — Drug Facts (SPL effective 2026-10-05, version 9)↗[Public]
FDA Cetirizine 10mg tab — Cetirizine HCl 10 mg tablets (OTC) — Drug Facts (SPL effective 2026-10-08, version 6)↗[Public]
FDA Loratadine 10mg tab — Loratadine 10 mg tablets (OTC) — Drug Facts (SPL effective 2026-10-07, version 6)↗[Public]
FDA Hydroxyzine solution — Hydroxyzine HCl oral solution 10 mg/5 mL — Prescribing Information (SPL effective 2026-07-21, version 10)↗[Public]
FDA Promethazine syrup — Promethazine HCl oral solution 6.25 mg/5 mL — Prescribing Information (SPL effective 2026-04-16, version 1)↗[Public]
FDA Carbamazepine susp. — Carbamazepine tablets, chewable, XR and oral suspension 100 mg/5 mL (Sun) — Prescribing Information (SPL effective 2026-08-30, version 12)↗[Public]
FDA Ondansetron sol. — Ondansetron oral solution 4 mg/5 mL — Prescribing Information (SPL effective 2026-03-31, version 2)↗[Public]
FDA Cipro (tab+susp) — Cipro (ciprofloxacin) tablets and oral suspension (Bayer) — Prescribing Information (SPL effective 2026-03-02, version 32)↗[Public]
FDA Claforan — Claforan (cefotaxime) for injection — Prescribing Information (SPL effective 2026-08-14, version 2)↗[Public]
FDA Ceftazidime — Ceftazidime for injection (WG Critical Care) — Prescribing Information (SPL effective 2026-06-24, version 10)↗[Public]
FDA Amikacin inj. — Amikacin sulfate injection 250 mg/mL (Sagent) — Prescribing Information (SPL effective 2026-07-27, version 10)↗[Public]
FDA Vancomycin inj. — Vancomycin hydrochloride for injection (Glenmark) — Prescribing Information (SPL effective 2026-10-08, version 1)↗[Public]
FDA Vancomycin caps — Vancomycin hydrochloride capsules (Cameron) — Prescribing Information (SPL effective 2026-08-17, version 6)↗[Public]
FDA Penicillin G K inj. — Penicillin G potassium for injection (WG Critical Care) — Prescribing Information (SPL effective 2026-06-24, version 13)↗[Public]
FDA Bicillin C-R — Bicillin C-R (penicillin G benzathine + procaine) — Prescribing Information (SPL effective 2026-07-21, version 29)↗[Public]
FDA Ampicillin-sulbactam — Ampicillin and sulbactam for injection (Sagent) — Prescribing Information (SPL effective 2026-07-24, version 18)↗[Public]
FDA Ethambutol — Ethambutol hydrochloride tablets (STI Pharma) — Prescribing Information (SPL effective 2026-05-05, version 9)↗[Public]
FDA Pyrazinamide — Pyrazinamide tablets 500 mg (ANI) — Prescribing Information (SPL effective 2026-03-02, version 2)↗[Public]
FDA Azithromycin inj. — Azithromycin for injection 500 mg (Sun) — Prescribing Information (SPL effective 2026-09-16, version 4)↗[Public]
FDA Doxycycline susp. — Doxycycline for oral suspension 25 mg/5 mL (Lupin) — Prescribing Information (SPL effective 2025-10-23, version 21)↗[Public]
FDA Cleocin Phosphate — Cleocin Phosphate (clindamycin injection 150 mg/mL) — Prescribing Information (SPL effective 2026-07-29, version 60)↗[Public]
FDA Clindamycin caps — Clindamycin hydrochloride capsules (Aurobindo) — Prescribing Information (SPL effective 2026-09-21, version 23)↗[Public]
FDA Metronidazole inj. — Metronidazole injection 500 mg/100 mL (WG Critical Care) — Prescribing Information (SPL effective 2026-10-06, version 4)↗[Public]
FDA Ampicillin inj. — Ampicillin for injection (Sagent) — Prescribing Information (SPL effective 2026-07-27, version 2)↗[Public]
FDA Cephalexin caps — Cephalexin capsules (Aurobindo) — Prescribing Information (SPL effective 2026-09-15, version 19)↗[Public]
FDA Erythromycin tabs — Erythromycin tablets 250/500 mg (Torrent) — Prescribing Information (SPL effective 2026-03-05, version 11)↗[Public]
FDA Neosporin — Neosporin Original (bacitracin/neomycin/polymyxin B) ointment — Drug Facts (SPL effective 2025-02-21, version 3)↗[Public]
FDA Coartem — Coartem (artemether/lumefantrine) tablets — Prescribing Information (SPL effective 2026-03-26, version 25)↗[Public]
FDA Malarone — Malarone (atovaquone/proguanil) tablets — Prescribing Information (SPL effective 2026-06-10, version 31)↗[Public]
FDA Mefloquine — Mefloquine hydrochloride tablets (Teva) — Prescribing Information (SPL effective 2025-09-26, version 13)↗[Public]
FDA Quinine sulfate — Quinine sulfate capsules 324 mg (Lupin) — Prescribing Information (SPL effective 2025-10-31, version 14)↗[Public]
FDA Egaten — Egaten (triclabendazole) tablets — Prescribing Information (SPL effective 2026-06-04, version 12)↗[Public]
FDA Humatin — Humatin (paromomycin) capsules — Prescribing Information (SPL effective 2025-11-13, version 3)↗[Public]
FDA Impavido — Impavido (miltefosine) capsules — Prescribing Information (SPL effective 2026-10-08, version 15)↗[Public]
FDA Ovide — Ovide (malathion) lotion 0.5% — Prescribing Information (SPL effective 2026-07-15, version 3)↗[Public]
FDA Eurax — Eurax (crotamiton) cream 10% — Prescribing Information (SPL effective 2025-12-17, version 2)↗[Public]
FDA Lamisil AT cream — Lamisil AT (terbinafine 1%) cream — Drug Facts (SPL effective 2025-11-18, version 6)↗[Public]
FDA Econazole cream — Econazole nitrate cream 1% (Encube) — Prescribing Information (SPL effective 2026-06-22, version 1)↗[Public]
FDA Clotrimazole troche — Clotrimazole lozenges 10 mg (Rising) — Prescribing Information (SPL effective 2025-03-27, version 2)↗[Public]
FDA Vfend IV — Vfend I.V. (voriconazole) for injection — Prescribing Information (SPL effective 2026-03-20, version 33)↗[Public]
FDA AmBisome — AmBisome (amphotericin B liposome) for injection — Prescribing Information (SPL effective 2026-10-02, version 14)↗[Public]
FDA Acyclovir tablets — Acyclovir tablets 400/800 mg (Avet) — Prescribing Information (SPL effective 2026-07-24, version 6)↗[Public]
FDA Acyclovir capsules — Acyclovir capsules 200 mg (Avet) — Prescribing Information (SPL effective 2026-07-08, version 8)↗[Public]
FDA Acyclovir injection — Acyclovir sodium injection 50 mg/mL (AuroMedics) — Prescribing Information (SPL effective 2017-09-18, version 2)↗[Public]
FDA Viread — Viread (tenofovir disoproxil fumarate) — Prescribing Information (SPL effective 2025-02-18, version 31)↗[Public]
FDA Baraclude — Baraclude (entecavir) tablets and oral solution — Prescribing Information (SPL effective 2019-11-06, version 42)↗[Public]
FDA Epclusa — Epclusa (sofosbuvir/velpatasvir) — Prescribing Information (SPL effective 2024-06-05, version 14)↗[Public]
FDA Truvada — Truvada (emtricitabine/tenofovir DF) — Prescribing Information (SPL effective 2025-07-16, version 32)↗[Public]
FDA Paxlovid — Paxlovid (nirmatrelvir; ritonavir) — Prescribing Information (SPL effective 2026-02-19, version 12)↗[Public]
FDA Xofluza — Xofluza (baloxavir marboxil) — Prescribing Information (SPL effective 2025-12-15, version 30)↗[Public]
FDA Adenosine inj. — Adenosine injection 3 mg/mL (Sagent) — Prescribing Information (SPL effective 2026-07-27, version 2)↗[Public]
FDA Cerebyx — Cerebyx (fosphenytoin sodium) injection — Prescribing Information (SPL effective 2025-08-28, version 38)↗[Public]
FDA Amiodarone inj. — Amiodarone hydrochloride injection 50 mg/mL — Prescribing Information (SPL effective 2026-01-16, version 6)↗[Public]
FDA Lorazepam inj. — Lorazepam injection 2 and 4 mg/mL (Hospira) — Prescribing Information (SPL effective 2026-07-10, version 28)↗[Public]
FDA Levetiracetam IV — Levetiracetam in sodium chloride injection (WG Critical Care) — Prescribing Information (SPL effective 2024-03-29, version 7)↗[Public]
FDA Ondansetron inj. — Ondansetron injection 2 mg/mL (Civica) — Prescribing Information (SPL effective 2026-04-19, version 4)↗[Public]
FDA Protopam — Protopam (pralidoxime chloride) for injection — Prescribing Information (SPL effective 2026-04-01, version 15)↗[Public]
FDA Deferoxamine — Deferoxamine mesylate for injection (Fresenius Kabi) — Prescribing Information (SPL effective 2026-06-15, version 9)↗[Public]
FDA Fomepizole — Fomepizole injection 1 g/mL (Zydus) — Prescribing Information (SPL effective 2025-11-20, version 8)↗[Public]
FDA ProvayBlue — ProvayBlue (methylene blue) injection 0.5% — Prescribing Information (SPL effective 2025-05-28, version 28)↗[Public]
FDA Protamine — Protamine sulfate injection 10 mg/mL (Fresenius Kabi) — Prescribing Information (SPL effective 2025-04-29, version 1)↗[Public]
FDA DigiFab — DigiFab (digoxin immune fab, ovine) — Prescribing Information (SPL effective 2026-09-29, version 11)↗[Public]
FDA Cyanokit — Cyanokit (hydroxocobalamin) 5 g for injection — Prescribing Information (SPL effective 2023-04-27, version 2)↗[Public]
FDA HyperTET — HyperTET (tetanus immune globulin, human) 250 units — Prescribing Information (SPL effective 2024-09-20, version 20)↗[Public]
FDA HyperRAB — HyperRAB (rabies immune globulin, human) 300 IU/mL — Prescribing Information (SPL effective 2024-09-20, version 10)↗[Public]
FDA HyperHEP B — HyperHEP B (hepatitis B immune globulin, human) — Prescribing Information (SPL effective 2024-09-20, version 26)↗[Public]
FDA Boostrix — Boostrix (Tdap vaccine) — Prescribing Information (SPL effective 2026-07-17, version 45)↗[Public]
FDA Imovax Rabies — Imovax Rabies (rabies vaccine) — Prescribing Information (SPL effective 2026-02-02, version 24)↗[Public]
FDA Engerix-B — Engerix-B (hepatitis B vaccine) — Prescribing Information (SPL effective 2026-05-14, version 35)↗[Public]
FDA Fluzone — Fluzone (influenza vaccine) 2026–2027 — Prescribing Information (SPL effective 2026-06-29, version 13)↗[Public]
FDA M-M-R II — M-M-R II (measles, mumps, rubella vaccine live) — Prescribing Information (SPL effective 2025-11-07, version 43)↗[Public]
FDA Varivax — Varivax (varicella vaccine live) — Prescribing Information (SPL effective 2026-08-06, version 48)↗[Public]
FDA Gardasil 9 — Gardasil 9 (HPV 9-valent vaccine) — Prescribing Information (SPL effective 2026-07-13, version 31)↗[Public]
FDA Prevnar 20 — Prevnar 20 (pneumococcal 20-valent conjugate vaccine) — Prescribing Information (SPL effective 2026-07-24, version 12)↗[Public]
FDA Havrix — Havrix (hepatitis A vaccine) — Prescribing Information (SPL effective 2026-05-14, version 33)↗[Public]
FDA Pitocin — Pitocin (oxytocin injection) — Prescribing Information (SPL effective 2026-05-05, version 15)↗[Public]
FDA Carboprost — Carboprost tromethamine injection 250 mcg/mL — Prescribing Information (SPL effective 2026-08-14, version 1)↗[Public]
FDA RhoGAM — RhoGAM Ultra-Filtered PLUS (Rho(D) immune globulin) — Prescribing Information (SPL effective 2025-07-24, version 19)↗[Public]
FDA Zurzuvae — Zurzuvae (zuranolone) capsules — Prescribing Information (SPL effective 2026-06-15, version 18)↗[Public]
FDA Methylergonovine inj — Methylergonovine maleate injection 0.2 mg/mL (American Regent) — Prescribing Information (SPL effective 2026-03-04, version 8)↗[Public]
FDA Prometrium — Prometrium (progesterone) capsules — Prescribing Information (SPL effective 2026-07-23, version 4)↗[Public]
FDA Veozah — Veozah (fezolinetant) tablets — Prescribing Information (SPL effective 2026-02-26, version 8)↗[Public]
FDA Clindesse — Clindesse (clindamycin phosphate) vaginal cream 2% — Prescribing Information (SPL effective 2025-01-30, version 12)↗[Public]
FDA Terconazole cream — Terconazole vaginal cream 0.4% (Fougera) — Prescribing Information (SPL effective 2026-01-28, version 11)↗[Public]
FDA Orilissa — Orilissa (elagolix) tablets — Prescribing Information (SPL effective 2025-12-19, version 112)↗[Public]
FDA Caffeine cit. oral — Caffeine citrate oral solution 20 mg/mL (Armas) — Prescribing Information (SPL effective 2023-07-31, version 2)↗[Public]
FDA Caffeine cit. inj. — Caffeine citrate injection 20 mg/mL (Eugia) — Prescribing Information (SPL effective 2025-04-19, version 6)↗[Public]
FDA Curosurf — Curosurf (poractant alfa) intratracheal suspension — Prescribing Information (SPL effective 2025-12-10, version 45)↗[Public]
FDA NeoProfen — NeoProfen (ibuprofen lysine) injection — Prescribing Information (SPL effective 2024-10-15, version 17)↗[Public]
FDA Sezaby — Sezaby (phenobarbital sodium) for injection — Prescribing Information (SPL effective 2025-12-23, version 7)↗[Public]
FDA Beyfortus — Beyfortus (nirsevimab-alip) injection — Prescribing Information (SPL effective 2026-07-13, version 32)↗[Public]
FDA Entresto — Entresto (sacubitril/valsartan) — Prescribing Information (SPL effective 2026-07-06, version 25)↗[Public]
FDA Corlanor — Corlanor (ivabradine) — Prescribing Information (SPL effective 2025-11-10, version 33)↗[Public]
FDA Bumetanide — Bumetanide tablets (Northstar) — Prescribing Information (SPL effective 2026-08-21, version 4)↗[Public]
FDA Torsemide — Torsemide tablets (AvKARE) — Prescribing Information (SPL effective 2026-02-11, version 9)↗[Public]
FDA Eplerenone — Eplerenone tablets (Breckenridge) — Prescribing Information (SPL effective 2026-03-17, version 8)↗[Public]
FDA Olmesartan — Olmesartan medoxomil tablets (Umedica) — Prescribing Information (SPL effective 2026-09-30, version 4)↗[Public]
FDA Nebivolol — Nebivolol tablets (Solco) — Prescribing Information (SPL effective 2026-01-31, version 5)↗[Public]
FDA Brilinta — Brilinta (ticagrelor) tablets — Prescribing Information (SPL effective 2026-05-07, version 56)↗[Public]
FDA Ranolazine ER — Ranolazine extended-release tablets (Zydus) — Prescribing Information (SPL effective 2026-09-18, version 5)↗[Public]
FDA Cilostazol — Cilostazol tablets (Apotex) — Prescribing Information (SPL effective 2026-09-10, version 11)↗[Public]
FDA Pentoxifylline ER — Pentoxifylline extended-release tablets 400 mg — Prescribing Information (SPL effective 2026-09-11, version 1)↗[Public]
FDA Labetalol inj. — Labetalol hydrochloride injection 5 mg/mL (Hospira) — Prescribing Information (SPL effective 2026-09-14, version 30)↗[Public]
FDA Hydralazine inj. — Hydralazine hydrochloride injection 20 mg/mL (Zydus) — Prescribing Information (SPL effective 2026-05-06, version 2)↗[Public]
FDA Ozempic — Ozempic (semaglutide) injection — Prescribing Information (SPL effective 2026-06-01, version 20)↗[Public]
FDA Victoza — Victoza (liraglutide) injection — Prescribing Information (SPL effective 2025-10-14, version 31)↗[Public]
FDA Mounjaro — Mounjaro (tirzepatide) injection — Prescribing Information (SPL effective 2026-08-27, version 40)↗[Public]
FDA Repaglinide — Repaglinide tablets (Northstar) — Prescribing Information (SPL effective 2025-09-15, version 2)↗[Public]
FDA Venofer — Venofer (iron sucrose) injection — Prescribing Information (SPL effective 2026-03-01, version 45)↗[Public]
FDA Injectafer — Injectafer (ferric carboxymaltose) injection — Prescribing Information (SPL effective 2026-08-19, version 30)↗[Public]
FDA Epogen — Epogen (epoetin alfa) — Prescribing Information (SPL effective 2026-06-23, version 137)↗[Public]
FDA Jadenu — Jadenu (deferasirox) tablets and granules — Prescribing Information (SPL effective 2025-12-11, version 26)↗[Public]
FDA Siklos — Siklos (hydroxyurea) tablets — Prescribing Information (SPL effective 2026-01-07, version 13)↗[Public]
FDA Renvela — Renvela (sevelamer carbonate) — Prescribing Information (SPL effective 2025-11-25, version 47)↗[Public]
FDA Calcium acetate — Calcium acetate capsules 667 mg (Rising) — Prescribing Information (SPL effective 2026-05-15, version 6)↗[Public]
FDA SPS suspension — Sodium polystyrene sulfonate suspension 15 g/60 mL (Burel) — Prescribing Information (SPL effective 2025-05-01, version 2)↗[Public]
FDA Lokelma — Lokelma (sodium zirconium cyclosilicate) — Prescribing Information (SPL effective 2024-02-08, version 28)↗[Public]
FDA Sensipar — Sensipar (cinacalcet) tablets — Prescribing Information (SPL effective 2025-12-07, version 136)↗[Public]
FDA Oxycodone IR — Oxycodone hydrochloride tablets (SpecGx) — Prescribing Information (SPL effective 2026-08-07, version 36)↗[Public]
FDA Morphine IR tab — Morphine sulfate tablets 15/30 mg (SpecGx) — Prescribing Information (SPL effective 2026-07-30, version 10)↗[Public]
FDA Indomethacin — Indomethacin capsules (Glenmark) — Prescribing Information (SPL effective 2025-12-19, version 13)↗[Public]
FDA Piroxicam — Piroxicam capsules (Teva) — Prescribing Information (SPL effective 2026-08-19, version 21)↗[Public]
FDA Voltaren gel — Voltaren Arthritis Pain (diclofenac sodium 1%) gel — Drug Facts (SPL effective 2025-02-11, version 13)↗[Public]
FDA Lidoderm — Lidoderm (lidocaine patch 5%) — Prescribing Information (SPL effective 2022-12-02, version 3)↗[Public]
FDA Methotrexate tab — Methotrexate tablets 2.5 mg (Alembic) — Prescribing Information (SPL effective 2026-05-18, version 6)↗[Public]
FDA Sulfasalazine DR — Sulfasalazine delayed-release tablets (Mylan) — Prescribing Information (SPL effective 2026-08-25, version 31)↗[Public]
FDA Leflunomide — Leflunomide tablets (Burel) — Prescribing Information (SPL effective 2026-05-01, version 10)↗[Public]
FDA Febuxostat — Febuxostat tablets (HEC) — Prescribing Information (SPL effective 2026-03-10, version 1)↗[Public]
FDA Risedronate DR — Risedronate sodium delayed-release tablets 35 mg (Mylan) — Prescribing Information (SPL effective 2026-02-03, version 7)↗[Public]
FDA Reclast — Reclast (zoledronic acid) 5 mg/100 mL injection — Prescribing Information (SPL effective 2026-02-03, version 3)↗[Public]
FDA Prolia — Prolia (denosumab) injection — Prescribing Information (SPL effective 2026-06-26, version 186)↗[Public]
FDA Raloxifene — Raloxifene hydrochloride tablets (Teva) — Prescribing Information (SPL effective 2021-08-01, version 12)↗[Public]
FDA Carafate — Carafate (sucralfate) 1 g tablets — Prescribing Information (SPL effective 2024-05-21, version 18)↗[Public]
FDA Motegrity — Motegrity (prucalopride) tablets — Prescribing Information (SPL effective 2025-07-17, version 12)↗[Public]
FDA Linzess — Linzess (linaclotide) capsules — Prescribing Information (SPL effective 2026-05-21, version 39)↗[Public]
FDA Budesonide EC — Budesonide delayed-release capsules 3 mg (Padagis) — Prescribing Information (SPL effective 2024-06-05, version 10)↗[Public]
FDA Azathioprine — Azathioprine tablets 50 mg (Glenmark) — Prescribing Information (SPL effective 2026-09-21, version 37)↗[Public]
FDA Voquezna — Voquezna (vonoprazan) tablets — Prescribing Information (SPL effective 2026-07-16, version 6)↗[Public]
FDA Retin-A Micro — Retin-A Micro (tretinoin) gel — Prescribing Information (SPL effective 2025-09-01, version 23)↗[Public]
FDA Tri-Luma — Tri-Luma (fluocinolone/hydroquinone/tretinoin) cream — Prescribing Information (SPL effective 2024-10-24, version 18)↗[Public]
FDA Soolantra — Soolantra (ivermectin) cream 1% — Prescribing Information (SPL effective 2024-10-24, version 8)↗[Public]
FDA Pimecrolimus — Pimecrolimus cream 1% (Oceanside) — Prescribing Information (SPL effective 2026-04-30, version 4)↗[Public]
FDA Desonide cream — Desonide cream 0.05% (Alembic) — Prescribing Information (SPL effective 2026-02-03, version 6)↗[Public]
FDA Imiquimod 3.75% — Imiquimod cream 3.75% — Prescribing Information (SPL effective 2026-09-22, version 1)↗[Public]
FDA Condylox — Condylox (podofilox) gel 0.5% — Prescribing Information (SPL effective 2024-01-29, version 8)↗[Public]
FDA Buprenorphine-nalox. — Buprenorphine and naloxone sublingual tablets (Hikma) — Prescribing Information (SPL effective 2026-07-26, version 32)↗[Public]
FDA Methadone 40 mg — Methadone hydrochloride tablets for oral suspension 40 mg (VistaPharm) — Prescribing Information (SPL effective 2026-02-09, version 22)↗[Public]
FDA Naltrexone — Naltrexone hydrochloride tablets 50 mg (SpecGx) — Prescribing Information (SPL effective 2026-09-04, version 15)↗[Public]
FDA Acamprosate DR — Acamprosate calcium delayed-release tablets 333 mg (Somerset) — Prescribing Information (SPL effective 2026-07-14, version 1)↗[Public]
FDA Disulfiram — Disulfiram tablets 250 mg (Alvogen) — Prescribing Information (SPL effective 2025-10-07, version 14)↗[Public]
FDA Vyvanse — Vyvanse (lisdexamfetamine) — Prescribing Information (SPL effective 2026-04-30, version 81)↗[Public]
FDA Guanfacine ER — Guanfacine extended-release tablets (Upsher-Smith) — Prescribing Information (SPL effective 2026-09-30, version 16)↗[Public]
FDA Trintellix — Trintellix (vortioxetine) tablets — Prescribing Information (SPL effective 2025-03-05, version 18)↗[Public]
FDA Pyridostigmine — Pyridostigmine bromide tablets (Method) — Prescribing Information (SPL effective 2026-02-12, version 2)↗[Public]
FDA Rasagiline — Rasagiline tablets (Alvogen) — Prescribing Information (SPL effective 2026-10-06, version 8)↗[Public]
FDA Vimpat — Vimpat (lacosamide) tablets, injection and oral solution — Prescribing Information (SPL effective 2026-05-12, version 63)↗[Public]
FDA Ethosuximide soln — Ethosuximide oral solution 250 mg/5 mL (Mylan) — Prescribing Information (SPL effective 2026-07-24, version 17)↗[Public]
FDA Onfi — Onfi (clobazam) tablets and oral suspension — Prescribing Information (SPL effective 2024-03-12, version 42)↗[Public]
FDA Nurtec ODT — Nurtec ODT (rimegepant) — Prescribing Information (SPL effective 2026-06-04, version 32)↗[Public]
FDA Vigamox — Vigamox (moxifloxacin 0.5%) ophthalmic solution — Prescribing Information (SPL effective 2026-01-22, version 4)↗[Public]
FDA Brimonidine 0.1% — Brimonidine tartrate ophthalmic solution 0.1% (Lifestar) — Prescribing Information (SPL effective 2026-09-03, version 6)↗[Public]
FDA Dorzolamide/timolol — Dorzolamide hydrochloride and timolol maleate ophthalmic solution (Aurobindo) — Prescribing Information (SPL effective 2026-08-13, version 7)↗[Public]
FDA Acetazolamide — Acetazolamide tablets (Ajanta) — Prescribing Information (SPL effective 2026-01-20, version 7)↗[Public]
FDA Restasis — Restasis MultiDose (cyclosporine 0.05%) ophthalmic emulsion — Prescribing Information (SPL effective 2025-08-21, version 15)↗[Public]
FDA TobraDex ST — TobraDex ST (tobramycin/dexamethasone) ophthalmic suspension — Prescribing Information (SPL effective 2025-04-01, version 3)↗[Public]
FDA Acular — Acular (ketorolac 0.5%) ophthalmic solution — Prescribing Information (SPL effective 2025-09-18, version 16)↗[Public]
FDA Norepinephrine bag — Norepinephrine bitartrate in sodium chloride injection (WG Critical Care) — Prescribing Information (SPL effective 2026-04-01, version 11)↗[Public]
FDA Dopamine premix — Dopamine hydrochloride and 5% dextrose injection (Baxter) — Prescribing Information (SPL effective 2020-11-11, version 18)↗[Public]
FDA Dobutamine — Dobutamine injection 12.5 mg/mL (Hospira) — Prescribing Information (SPL effective 2026-05-27, version 19)↗[Public]
FDA Vasostrict — Vasostrict (vasopressin) injection — Prescribing Information (SPL effective 2026-04-21, version 49)↗[Public]
FDA Brevibloc — Brevibloc (esmolol) injection — Prescribing Information (SPL effective 2025-03-14, version 15)↗[Public]
FDA Activase — Activase (alteplase) for injection — Prescribing Information (SPL effective 2026-01-20, version 15)↗[Public]
FDA NaHCO3 1.26% — Sodium bicarbonate injection 12.6 mg/mL (0.150 mEq/mL) (Baxter) — Prescribing Information (SPL effective 2026-08-14, version 1)↗[Public]
FDA KCl oral solution — Potassium chloride oral solution 10%/20% (Granules) — Prescribing Information (SPL effective 2026-10-08, version 5)↗[Public]
FDA KCl ER tablet — Potassium chloride extended-release tablets 10 mEq (Granules) — Prescribing Information (SPL effective 2026-10-07, version 5)↗[Public]
FDA KCl concentrate — Potassium chloride for injection concentrate 2 mEq/mL (Hospira) — Prescribing Information (SPL effective 2026-07-01, version 23)↗[Public]
FDA Samsca — Samsca (tolvaptan) tablets — Prescribing Information (SPL effective 2026-05-07, version 23)↗[Public]
FDA Streptomycin — Streptomycin for injection 1 g (XGen) — Prescribing Information (SPL effective 2026-01-21, version 15)↗[Public]
FDA Preparation H oint. — Preparation H ointment (phenylephrine/petrolatum/mineral oil) — Drug Facts (SPL effective 2024-02-29, version 15)↗[Public]
FDA HC suppository — Hydrocortisone acetate rectal suppositories 25/30 mg (Aarna) — Prescribing Information (SPL effective 2026-04-16, version 1)↗[Public]
FDA Rectiv — Rectiv (nitroglycerin 0.4%) ointment — Prescribing Information (SPL effective 2026-09-08, version 16)↗[Public]
FDA Xdemvy — Xdemvy (lotilaner 0.25%) ophthalmic solution — Prescribing Information (SPL effective 2024-08-10, version 3)↗[Public]
FDA Xenical — Xenical (orlistat) 120 mg capsules — Prescribing Information (SPL effective 2026-01-09, version 10)↗[Public]
FDA Wegovy — Wegovy (semaglutide) injection and tablets — Prescribing Information (SPL effective 2026-06-18, version 19)↗[Public]
FDA Saxenda — Saxenda (liraglutide) injection — Prescribing Information (SPL effective 2026-02-25, version 22)↗[Public]
FDA Zepbound — Zepbound (tirzepatide) injection — Prescribing Information (SPL effective 2026-08-28, version 40)↗[Public]
FDA Opzelura — Opzelura (ruxolitinib 1.5%) cream — Prescribing Information (SPL effective 2026-06-30, version 14)↗[Public]
FDA Qbrexza — Qbrexza (glycopyrronium 2.4%) cloth — Prescribing Information (SPL effective 2026-05-21, version 5)↗[Public]
FDA Zelsuvmi — Zelsuvmi (berdazimer 10.3%) topical gel — Prescribing Information (SPL effective 2025-07-08, version 3)↗[Public]
FDA Rabeprazole — Rabeprazole sodium delayed-release tablets — Prescribing Information (SPL effective 2026-08-28, version 19)↗[Public]
FDA Granisetron tab — Granisetron hydrochloride tablets 1 mg — Prescribing Information (SPL effective 2024-02-29, version 12)↗[Public]
FDA Prasugrel — Prasugrel tablets 5/10 mg — Prescribing Information (SPL effective 2026-04-08, version 9)↗[Public]
FDA Doxazosin — Doxazosin tablets (Apotex) — Prescribing Information (SPL effective 2026-09-10, version 16)↗[Public]
FDA Terazosin — Terazosin capsules — Prescribing Information (SPL effective 2026-09-03, version 1)↗[Public]
FDA Sotalol — Sotalol hydrochloride tablets (Apotex) — Prescribing Information (SPL effective 2026-09-17, version 18)↗[Public]
FDA Propafenone — Propafenone hydrochloride tablets — Prescribing Information (SPL effective 2025-09-01, version 3)↗[Public]
FDA Flecainide — Flecainide acetate tablets — Prescribing Information (SPL effective 2026-06-11, version 11)↗[Public]
FDA Amiloride — Amiloride hydrochloride tablets 5 mg — Prescribing Information (SPL effective 2026-07-28, version 13)↗[Public]
FDA Metolazone — Metolazone tablets 2.5/5/10 mg — Prescribing Information (SPL effective 2026-04-01, version 4)↗[Public]
FDA Humalog — Humalog (insulin lispro) injection — Prescribing Information (SPL effective 2026-06-16, version 87)↗[Public]
FDA Tresiba — Tresiba (insulin degludec) injection — Prescribing Information (SPL effective 2022-07-01, version 14)↗[Public]
FDA Trulicity — Trulicity (dulaglutide) injection — Prescribing Information (SPL effective 2026-06-16, version 62)↗[Public]
FDA Forteo — Forteo (teriparatide) injection — Prescribing Information (SPL effective 2026-08-03, version 44)↗[Public]
FDA Ibandronate — Ibandronate sodium tablets 150 mg — Prescribing Information (SPL effective 2026-08-26, version 6)↗[Public]
FDA Liothyronine — Liothyronine sodium tablets 5/25/50 mcg — Prescribing Information (SPL effective 2020-07-01, version 4)↗[Public]
FDA Octreotide — Octreotide acetate injection — Prescribing Information (SPL effective 2026-01-13, version 12)↗[Public]
FDA Meropenem — Meropenem for injection 500 mg / 1 g — Prescribing Information (SPL effective 2020-05-29, version 6)↗[Public]
FDA Primaxin — Primaxin (imipenem and cilastatin) for injection — Prescribing Information (SPL effective 2024-07-05, version 34)↗[Public]
FDA Pip-tazo — Piperacillin and tazobactam for injection 40.5 g pharmacy bulk — Prescribing Information (SPL effective 2026-10-05, version 8)↗[Public]
FDA Cefepime — Cefepime for injection 1 g / 2 g — Prescribing Information (SPL effective 2026-06-23, version 17)↗[Public]
FDA Linezolid tab — Linezolid tablets 600 mg — Prescribing Information (SPL effective 2026-08-24, version 3)↗[Public]
FDA Coly-Mycin M — Coly-Mycin M Parenteral (colistimethate) 150 mg — Prescribing Information (SPL effective 2026-06-08, version 27)↗[Public]
FDA Tivicay — Tivicay / Tivicay PD (dolutegravir) — Prescribing Information (SPL effective 2026-08-25, version 34)↗[Public]
FDA Lamivudine — Lamivudine tablets 150/300 mg (Apotex) — Prescribing Information (SPL effective 2026-09-14, version 27)↗[Public]
FDA Retrovir — Retrovir (zidovudine) capsules, tablets and syrup — Prescribing Information (SPL effective 2024-11-13, version 33)↗[Public]
FDA Hydromorphone tab — Hydromorphone hydrochloride tablets 2/4/8 mg (SpecGx) — Prescribing Information (SPL effective 2026-07-02, version 29)↗[Public]
FDA Nucynta — Nucynta (tapentadol) tablets — Prescribing Information (SPL effective 2025-12-30, version 7)↗[Public]
FDA Fentanyl inj. — Fentanyl citrate injection 50 mcg/mL — Prescribing Information (SPL effective 2026-08-24, version 35)↗[Public]
FDA Orphenadrine ER — Orphenadrine citrate extended-release tablets 100 mg (Lupin) — Prescribing Information (SPL effective 2025-09-10, version 15)↗[Public]
FDA Desvenlafaxine — Desvenlafaxine extended-release tablets — Prescribing Information (SPL effective 2026-08-21, version 7)↗[Public]
FDA Invega — Invega (paliperidone) extended-release tablets — Prescribing Information (SPL effective 2025-01-31, version 43)↗[Public]
FDA Latuda — Latuda (lurasidone) tablets — Prescribing Information (SPL effective 2025-01-31, version 37)↗[Public]
FDA Zonegran — Zonegran (zonisamide) capsules 25/100 mg — Prescribing Information (SPL effective 2026-09-23, version 13)↗[Public]
FDA Briviact — Briviact (brivaracetam) tablets, oral solution and injection — Prescribing Information (SPL effective 2026-08-20, version 27)↗[Public]
FDA Daliresp — Daliresp (roflumilast) tablets — Prescribing Information (SPL effective 2020-03-12, version 15)↗[Public]
FDA Avodart — Avodart (dutasteride) 0.5 mg capsules — Prescribing Information (SPL effective 2025-03-12, version 4)↗[Public]
FDA Myrbetriq — Myrbetriq (mirabegron) extended-release tablets and granules — Prescribing Information (SPL effective 2024-08-01, version 17)↗[Public]
FDA Veregen — Veregen (sinecatechins) 15% ointment — Prescribing Information (SPL effective 2022-11-10, version 1)↗[Public]
FDA RID kit — RID lice treatment (pyrethrum extract 0.33% + piperonyl butoxide 4%) — Drug Facts (SPL effective 2026-06-25, version 5)↗[Public]
FDA Ertapenem — Ertapenem for injection 1 g (Apotex) — Prescribing Information (SPL effective 2026-10-01, version 1)↗[Public]
FDA Amphotericin B — Amphotericin B for injection 50 mg (conventional, X-Gen) — Prescribing Information (SPL effective 2022-01-03, version 13)↗[Public]
FDA Cresemba — Cresemba (isavuconazonium sulfate) capsules and injection — Prescribing Information (SPL effective 2025-04-25, version 21)↗[Public]
FDA Riluzole — Riluzole tablets 50 mg — Prescribing Information (SPL effective 2026-10-12, version 9)↗[Public]
FDA Radicava — Radicava / Radicava ORS (edaravone) — Prescribing Information (SPL effective 2026-05-05, version 29)↗[Public]
FDA Tetrabenazine — Tetrabenazine tablets 12.5/25 mg (Apotex) — Prescribing Information (SPL effective 2026-09-18, version 7)↗[Public]
FDA Austedo — Austedo / Austedo XR (deutetrabenazine) — Prescribing Information (SPL effective 2025-02-28, version 35)↗[Public]
FDA Ingrezza — Ingrezza / Ingrezza Sprinkle (valbenazine) capsules — Prescribing Information (SPL effective 2026-04-17, version 34)↗[Public]
FDA Emflaza — Emflaza (deflazacort) tablets and oral suspension — Prescribing Information (SPL effective 2026-10-13, version 22)↗[Public]
FDA Firdapse — Firdapse (amifampridine) 10 mg tablets — Prescribing Information (SPL effective 2026-04-16, version 15)↗[Public]
FDA Keveyis — Keveyis (dichlorphenamide) 50 mg tablets — Prescribing Information (SPL effective 2026-03-04, version 9)↗[Public]
FDA Tecfidera — Tecfidera (dimethyl fumarate) delayed-release capsules — Prescribing Information (SPL effective 2025-06-04, version 55)↗[Public]
FDA Aubagio — Aubagio (teriflunomide) tablets — Prescribing Information (SPL effective 2026-02-20, version 28)↗[Public]
FDA Gilenya — Gilenya (fingolimod) capsules — Prescribing Information (SPL effective 2026-07-22, version 40)↗[Public]
FDA Diprivan — Diprivan (propofol) injectable emulsion — Prescribing Information (SPL effective 2025-09-11, version 10)↗[Public]
FDA Ketamine — Ketamine hydrochloride injection (Eugia) — Prescribing Information (SPL effective 2026-09-24, version 7)↗[Public]
FDA Amidate — Amidate (etomidate) injection 2 mg/mL — Prescribing Information (SPL effective 2026-05-20, version 27)↗[Public]
FDA Precedex — Precedex (dexmedetomidine) in 0.9% NaCl 4 mcg/mL — Prescribing Information (SPL effective 2026-06-17, version 6)↗[Public]
FDA Quelicin — Quelicin (succinylcholine) injection 20 mg/mL — Prescribing Information (SPL effective 2026-08-18, version 31)↗[Public]
FDA Rocuronium — Rocuronium bromide injection 10 mg/mL (Baxter) — Prescribing Information (SPL effective 2026-10-01, version 1)↗[Public]
FDA Neostigmine — Neostigmine methylsulfate injection 0.5/1 mg/mL (Par) — Prescribing Information (SPL effective 2026-10-09, version 11)↗[Public]
FDA Bridion — Bridion (sugammadex) injection 100 mg/mL — Prescribing Information (SPL effective 2026-03-13, version 26)↗[Public]
FDA Marcaine Spinal — Marcaine Spinal (bupivacaine 0.75% in dextrose 8.25%) — Prescribing Information (SPL effective 2026-06-23, version 27)↗[Public]
FDA Marcaine — Marcaine (bupivacaine hydrochloride) injection 0.25/0.5/0.75% — Prescribing Information (SPL effective 2026-06-24, version 1)↗[Public]
FDA Fentanyl patch — Fentanyl transdermal system (SpecGx) — Prescribing Information (SPL effective 2026-04-30, version 58)↗[Public]
FDA IPOL — IPOL (inactivated poliovirus vaccine) — Prescribing Information (SPL effective 2026-06-10, version 15)↗[Public]
FDA Rotarix — Rotarix (rotavirus vaccine, live, oral) — Prescribing Information (SPL effective 2026-09-25, version 32)↗[Public]
FDA Menveo — Menveo (meningococcal ACWY conjugate vaccine) — Prescribing Information (SPL effective 2025-03-31, version 20)↗[Public]
FDA Shingrix — Shingrix (zoster vaccine recombinant, adjuvanted) — Prescribing Information (SPL effective 2026-08-31, version 24)↗[Public]
FDA Arexvy — Arexvy (RSV vaccine recombinant, adjuvanted) — Prescribing Information (SPL effective 2026-07-27, version 13)↗[Public]
FDA Comirnaty — Comirnaty (COVID-19 vaccine, mRNA) — Prescribing Information (SPL effective 2026-09-02, version 22)↗[Public]
FDA BCG vaccine — BCG vaccine (Tice strain, percutaneous) — Prescribing Information (SPL effective 2024-10-11, version 20)↗[Public]
FDA Tubersol — Tubersol (tuberculin PPD, Mantoux) — Prescribing Information (SPL effective 2026-05-01, version 18)↗[Public]
FDA Humira — Humira (adalimumab) injection — Prescribing Information (SPL effective 2025-12-23, version 4)↗[Public]
FDA Enbrel — Enbrel (etanercept) — Prescribing Information (SPL effective 2026-05-11, version 218)↗[Public]
FDA Remicade — Remicade (infliximab) 100 mg vial — Prescribing Information (SPL effective 2025-06-03, version 37)↗[Public]
FDA Rituxan — Rituxan (rituximab) IV — Prescribing Information (SPL effective 2025-01-06, version 36)↗[Public]
FDA Dupixent — Dupixent (dupilumab) injection — Prescribing Information (SPL effective 2026-04-22, version 60)↗[Public]
FDA Xolair — Xolair (omalizumab) — Prescribing Information (SPL effective 2026-08-13, version 32)↗[Public]
FDA Stelara — Stelara (ustekinumab) — Prescribing Information (SPL effective 2026-09-08, version 49)↗[Public]
FDA Cosentyx — Cosentyx (secukinumab) — Prescribing Information (SPL effective 2026-08-25, version 30)↗[Public]
FDA Mycophenolate — Mycophenolate mofetil capsules 250 mg — Prescribing Information (SPL effective 2026-09-23, version 3)↗[Public]
FDA Prograf — Prograf (tacrolimus) capsules, granules and injection — Prescribing Information (SPL effective 2023-08-25, version 30)↗[Public]
FDA Neoral — Neoral (cyclosporine, modified) capsules and oral solution — Prescribing Information (SPL effective 2026-08-10, version 30)↗[Public]
FDA Xeljanz — Xeljanz / Xeljanz XR (tofacitinib) — Prescribing Information (SPL effective 2026-09-25, version 55)↗[Public]
FDA Olumiant — Olumiant (baricitinib) tablets — Prescribing Information (SPL effective 2026-09-25, version 31)↗[Public]
FDA Rinvoq — Rinvoq (upadacitinib) extended-release tablets — Prescribing Information (SPL effective 2026-06-30, version 101)↗[Public]
FDA Otezla — Otezla / Otezla XR (apremilast) — Prescribing Information (SPL effective 2026-09-02, version 38)↗[Public]
FDA Tamoxifen — Tamoxifen citrate tablets 10/20 mg (Mylan) — Prescribing Information (SPL effective 2021-07-02, version 14)↗[Public]
FDA Anastrozole — Anastrozole tablets 1 mg — Prescribing Information (SPL effective 2026-08-18, version 14)↗[Public]
FDA Bicalutamide — Bicalutamide tablets 50 mg — Prescribing Information (SPL effective 2026-02-27, version 3)↗[Public]
FDA Imatinib — Imatinib mesylate tablets 100/400 mg — Prescribing Information (SPL effective 2026-08-31, version 5)↗[Public]
FDA Capecitabine — Capecitabine tablets 150/500 mg — Prescribing Information (SPL effective 2026-07-21, version 2)↗[Public]
FDA Neupogen — Neupogen (filgrastim) injection — Prescribing Information (SPL effective 2026-07-23, version 166)↗[Public]
FDA Savaysa — Savaysa (edoxaban) tablets — Prescribing Information (SPL effective 2025-07-10, version 28)↗[Public]
FDA Fondaparinux — Fondaparinux sodium injection (Mylan) — Prescribing Information (SPL effective 2024-12-15, version 12)↗[Public]
FDA Argatroban — Argatroban in 0.9% NaCl 1 mg/mL — Prescribing Information (SPL effective 2026-09-22, version 6)↗[Public]
FDA Bivalirudin — Bivalirudin for injection 250 mg — Prescribing Information (SPL effective 2026-08-20, version 2)↗[Public]
FDA TNKase — TNKase (tenecteplase) 25 mg / 50 mg — Prescribing Information (SPL effective 2025-12-15, version 4)↗[Public]
FDA Repatha — Repatha (evolocumab) — Prescribing Information (SPL effective 2026-08-19, version 32)↗[Public]
FDA Praluent — Praluent (alirocumab) — Prescribing Information (SPL effective 2026-07-07, version 35)↗[Public]
FDA Leqvio — Leqvio (inclisiran) 284 mg/1.5 mL — Prescribing Information (SPL effective 2026-08-19, version 13)↗[Public]
FDA Nexletol — Nexletol (bempedoic acid) 180 mg — Prescribing Information (SPL effective 2026-06-25, version 20)↗[Public]
FDA Vascepa — Vascepa (icosapent ethyl) capsules — Prescribing Information (SPL effective 2026-03-23, version 21)↗[Public]
FDA Kerendia — Kerendia (finerenone) tablets — Prescribing Information (SPL effective 2026-09-21, version 15)↗[Public]
FDA Verquvo — Verquvo (vericiguat) tablets — Prescribing Information (SPL effective 2026-01-21, version 13)↗[Public]
FDA Fycompa — Fycompa (perampanel) tablets and oral suspension — Prescribing Information (SPL effective 2022-12-28, version 60)↗[Public]
FDA Xcopri — Xcopri (cenobamate) tablets — Prescribing Information (SPL effective 2025-08-25, version 46)↗[Public]
FDA Rufinamide susp. — Rufinamide oral suspension 40 mg/mL — Prescribing Information (SPL effective 2026-08-07, version 9)↗[Public]
FDA Vigabatrin — Vigabatrin for oral solution 500 mg packet — Prescribing Information (SPL effective 2026-01-20, version 30)↗[Public]
FDA Entacapone — Entacapone tablets 200 mg (Macleods) — Prescribing Information (SPL effective 2026-05-13, version 7)↗[Public]
FDA Ongentys — Ongentys (opicapone) capsules — Prescribing Information (SPL effective 2025-10-15, version 9)↗[Public]
FDA Xadago — Xadago (safinamide) tablets — Prescribing Information (SPL effective 2026-10-05, version 22)↗[Public]
FDA Modafinil — Modafinil tablets 100/200 mg — Prescribing Information (SPL effective 2026-09-03, version 14)↗[Public]
FDA Xyrem — Xyrem (sodium oxybate) oral solution 0.5 g/mL — Prescribing Information (SPL effective 2025-07-01, version 27)↗[Public]
FDA Wakix — Wakix (pitolisant) tablets — Prescribing Information (SPL effective 2026-02-13, version 18)↗[Public]
FDA Belsomra — Belsomra (suvorexant) tablets — Prescribing Information (SPL effective 2025-03-10, version 21)↗[Public]
FDA Aimovig — Aimovig (erenumab) — Prescribing Information (SPL effective 2026-07-14, version 25)↗[Public]
FDA Emgality — Emgality (galcanezumab) — Prescribing Information (SPL effective 2026-06-05, version 17)↗[Public]
FDA Ubrelvy — Ubrelvy (ubrogepant) tablets — Prescribing Information (SPL effective 2025-06-05, version 28)↗[Public]
FDA Vraylar — Vraylar (cariprazine) capsules — Prescribing Information (SPL effective 2025-12-18, version 32)↗[Public]
FDA Rexulti — Rexulti (brexpiprazole) tablets — Prescribing Information (SPL effective 2026-05-06, version 26)↗[Public]
FDA Spravato — Spravato (esketamine) nasal spray — Prescribing Information (SPL effective 2026-09-22, version 21)↗[Public]
FDA Cancidas — Cancidas (caspofungin) for injection 50/70 mg — Prescribing Information (SPL effective 2024-10-11, version 42)↗[Public]
FDA Veklury — Veklury (remdesivir) for injection 100 mg — Prescribing Information (SPL effective 2026-07-29, version 24)↗[Public]
FDA Prepidil — Prepidil (dinoprostone 0.5 mg) endocervical gel — Prescribing Information (SPL effective 2025-10-22, version 23)↗[Public]
FDA Levemir — Levemir (insulin detemir) — Prescribing Information (repackager listing) (SPL effective 2024-10-09, version 24)↗[Public]
FDA Apidra — Apidra (insulin glulisine) — Prescribing Information (SPL effective 2025-11-25, version 28)↗[Public]
FDA Evenity — Evenity (romosozumab) 105 mg/1.17 mL — Prescribing Information (SPL effective 2026-07-16, version 21)↗[Public]
FDA Cardene IV — Cardene I.V. (nicardipine) premixed 0.1/0.2 mg/mL — Prescribing Information (SPL effective 2026-04-13, version 11)↗[Public]
FDA Cleviprex — Cleviprex (clevidipine) emulsion 0.5 mg/mL — Prescribing Information (SPL effective 2022-11-09, version 4)↗[Public]
FDA Nipride RTU — Nipride RTU (sodium nitroprusside) 0.2/0.5 mg/mL — Prescribing Information (SPL effective 2018-07-20, version 6)↗[Public]
FDA Milrinone — Milrinone lactate injection 1 mg/mL (Mullan) — Prescribing Information (SPL effective 2026-07-27, version 5)↗[Public]
FDA Isoproterenol — Isoproterenol hydrochloride injection 0.2 mg/mL (Amphastar) — Prescribing Information (SPL effective 2022-10-01, version 3)↗[Public]
FDA Kengreal — Kengreal (cangrelor) for injection 50 mg — Prescribing Information (SPL effective 2025-10-21, version 10)↗[Public]
FDA Fragmin — Fragmin (dalteparin) injection — Prescribing Information (SPL effective 2025-09-30, version 27)↗[Public]
FDA Praxbind — Praxbind (idarucizumab) 2.5 g/50 mL — Prescribing Information (SPL effective 2024-01-23, version 8)↗[Public]
FDA Andexxa — Andexxa (andexanet alfa) 200 mg vial — Prescribing Information (SPL effective 2025-05-23, version 7)↗[Public]
FDA Aminocaproic acid — Aminocaproic acid tablets 500/1000 mg — Prescribing Information (SPL effective 2026-09-09, version 1)↗[Public]
FDA Dipyridamole — Dipyridamole tablets 25/50/75 mg (Amneal) — Prescribing Information (SPL effective 2026-04-15, version 8)↗[Public]
FDA Ryanodex — Ryanodex (dantrolene sodium) 250 mg for injectable suspension — Prescribing Information (SPL effective 2024-10-30, version 10)↗[Public]
FDA Multaq — Multaq (dronedarone) 400 mg tablets — Prescribing Information (SPL effective 2025-05-29, version 37)↗[Public]
FDA Tikosyn — Tikosyn (dofetilide) capsules — Prescribing Information (SPL effective 2026-04-21, version 30)↗[Public]
FDA Nadolol — Nadolol tablets 20/40/80 mg — Prescribing Information (SPL effective 2026-09-07, version 3)↗[Public]
FDA Edecrin — Edecrin (ethacrynic acid) tablets / Sodium Edecrin IV — Prescribing Information (SPL effective 2020-08-31, version 10)↗[Public]
FDA Cefoxitin — Cefoxitin for injection (WG Critical Care) — Prescribing Information (SPL effective 2026-08-24, version 8)↗[Public]
FDA Azactam — Azactam (aztreonam) for injection — Prescribing Information (SPL effective 2025-12-15, version 15)↗[Public]
FDA Tygacil — Tygacil (tigecycline) 50 mg — Prescribing Information (SPL effective 2025-11-18, version 50)↗[Public]
FDA Cubicin RF — Cubicin RF (daptomycin) 500 mg — Prescribing Information (SPL effective 2025-03-17, version 22)↗[Public]
FDA Sivextro — Sivextro (tedizolid) tablets and injection — Prescribing Information (SPL effective 2026-02-27, version 34)↗[Public]
FDA Dificid — Dificid (fidaxomicin) tablets and oral suspension — Prescribing Information (SPL effective 2024-10-16, version 22)↗[Public]
FDA Dapsone — Dapsone tablets 25/100 mg (Macleods) — Prescribing Information (SPL effective 2026-07-20, version 1)↗[Public]
FDA Sirturo — Sirturo (bedaquiline) 20/100 mg tablets — Prescribing Information (SPL effective 2025-10-17, version 33)↗[Public]
FDA Noxafil — Noxafil (posaconazole) injection, delayed-release tablets, oral suspension — Prescribing Information (SPL effective 2026-02-13, version 56)↗[Public]
FDA Micafungin premix — Micafungin in sodium chloride injection 1 mg/mL (Baxter) — Prescribing Information (SPL effective 2023-09-29, version 6)↗[Public]
FDA Eraxis — Eraxis (anidulafungin) 50/100 mg — Prescribing Information (SPL effective 2025-08-19, version 24)↗[Public]
FDA Flucytosine — Flucytosine capsules 250/500 mg — Prescribing Information (SPL effective 2026-01-08, version 4)↗[Public]
FDA Relenza — Relenza (zanamivir) inhalation powder — Prescribing Information (SPL effective 2023-10-24, version 34)↗[Public]
FDA Ganciclovir — Ganciclovir for injection 500 mg (Par) — Prescribing Information (SPL effective 2026-09-25, version 8)↗[Public]
FDA Valcyte — Valcyte (valganciclovir) tablets and oral solution — Prescribing Information (SPL effective 2025-12-08, version 24)↗[Public]
FDA Foscavir — Foscavir (foscarnet) 24 mg/mL — Prescribing Information (SPL effective 2025-12-11, version 16)↗[Public]
FDA Vemlidy — Vemlidy (tenofovir alafenamide) 25 mg — Prescribing Information (SPL effective 2025-07-14, version 17)↗[Public]
FDA Ribavirin caps — Ribavirin capsules 200 mg (Aurobindo) — Prescribing Information (SPL effective 2024-02-06, version 21)↗[Public]
FDA Efavirenz — Efavirenz tablets 600 mg (Cipla) — Prescribing Information (SPL effective 2024-03-31, version 7)↗[Public]
FDA Isentress — Isentress / Isentress HD (raltegravir) — Prescribing Information (SPL effective 2024-10-18, version 71)↗[Public]
FDA Biktarvy — Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) — Prescribing Information (SPL effective 2026-09-09, version 26)↗[Public]
FDA Prezista — Prezista (darunavir) tablets and oral suspension — Prescribing Information (SPL effective 2025-08-29, version 58)↗[Public]
FDA Reyataz — Reyataz (atazanavir) capsules and oral powder — Prescribing Information (SPL effective 2024-12-05, version 37)↗[Public]
FDA Abacavir — Abacavir tablets 300 mg (Aurobindo) — Prescribing Information (SPL effective 2026-09-21, version 17)↗[Public]
FDA Edurant — Edurant / Edurant PED (rilpivirine) — Prescribing Information (SPL effective 2025-08-28, version 28)↗[Public]
FDA Cabenuva — Cabenuva (cabotegravir + rilpivirine extended-release injectable) — Prescribing Information (SPL effective 2025-11-26, version 16)↗[Public]
FDA Daraprim — Daraprim (pyrimethamine) 25 mg tablets — Prescribing Information (SPL effective 2023-12-07, version 1)↗[Public]
FDA Genotropin — Genotropin (somatropin) for injection — Prescribing Information (SPL effective 2026-08-04, version 37)↗[Public]
FDA Lupron Depot — Lupron Depot 7.5/22.5/30/45 mg (leuprolide acetate, prostate cancer) — Prescribing Information (SPL effective 2026-03-15, version 1543)↗[Public]
FDA Zoladex 3.6 — Zoladex (goserelin implant) 3.6 mg — Prescribing Information (SPL effective 2026-03-24, version 9)↗[Public]
FDA Firmagon — Firmagon (degarelix) for injection — Prescribing Information (SPL effective 2024-01-30, version 18)↗[Public]
FDA Signifor — Signifor (pasireotide) injection — Prescribing Information (SPL effective 2026-02-17, version 20)↗[Public]
FDA Zemplar injection — Zemplar (paricalcitol) injection — Prescribing Information (SPL effective 2024-08-01, version 1483)↗[Public]
FDA Invokana — Invokana (canagliflozin) tablets — Prescribing Information (SPL effective 2026-06-11, version 32)↗[Public]
FDA Steglatro — Steglatro (ertugliflozin) tablets — Prescribing Information (SPL effective 2026-06-03, version 17)↗[Public]
FDA Byetta — Byetta (exenatide) injection — Prescribing Information (SPL effective 2025-09-02, version 26)↗[Public]
FDA Symlin — Symlin (pramlintide) injection — Prescribing Information (SPL effective 2019-12-18, version 18)↗[Public]
FDA Proglycem — Proglycem (diazoxide) oral suspension 50 mg/mL — Prescribing Information (SPL effective 2026-10-06, version 17)↗[Public]
FDA Aranesp — Aranesp (darbepoetin alfa) injection — Prescribing Information (SPL effective 2026-07-07, version 161)↗[Public]
FDA Cyanocobalamin inj — Cyanocobalamin injection 1000 mcg/mL (American Regent/BluePoint) — Prescribing Information (SPL effective 2026-10-09, version 3)↗[Public]
FDA Promacta — Promacta (eltrombopag) tablets and oral suspension — Prescribing Information (SPL effective 2025-12-18, version 31)↗[Public]
FDA Nplate — Nplate (romiplostim) for injection — Prescribing Information (SPL effective 2026-06-23, version 162)↗[Public]
FDA Hemlibra — Hemlibra (emicizumab-kxwh) injection — Prescribing Information (SPL effective 2025-07-11, version 17)↗[Public]
FDA Saphris — Saphris (asenapine) sublingual tablets — Prescribing Information (SPL effective 2025-01-31, version 22)↗[Public]
FDA Fanapt — Fanapt (iloperidone) tablets — Prescribing Information (SPL effective 2026-05-06, version 35)↗[Public]
FDA Caplyta — Caplyta (lumateperone) capsules — Prescribing Information (SPL effective 2025-06-20, version 27)↗[Public]
FDA Fluphenazine — Fluphenazine hydrochloride tablets USP — Prescribing Information (SPL effective 2026-04-14, version 13)↗[Public]
FDA Loxapine — Loxapine capsules USP (Watson/Actavis) — Prescribing Information (SPL effective 2025-03-31, version 20)↗[Public]
FDA Pimozide — Pimozide tablets USP 1/2 mg (Par) — Prescribing Information (SPL effective 2026-08-12, version 5)↗[Public]
FDA Aptiom — Aptiom (eslicarbazepine acetate) tablets — Prescribing Information (SPL effective 2023-11-10, version 16)↗[Public]
FDA Felbatol — Felbatol (felbamate) tablets and oral suspension — Prescribing Information (SPL effective 2025-08-15, version 16)↗[Public]
FDA Diacomit — Diacomit (stiripentol) capsules and powder for oral suspension — Prescribing Information (SPL effective 2026-04-27, version 8)↗[Public]
FDA Fintepla — Fintepla (fenfluramine) oral solution 2.2 mg/mL — Prescribing Information (SPL effective 2025-10-27, version 16)↗[Public]
FDA Primidone — Primidone tablets USP 50/250 mg — Prescribing Information (SPL effective 2026-09-01, version 1)↗[Public]
FDA Galantamine — Galantamine tablets USP 4/8/12 mg — Prescribing Information (SPL effective 2026-06-01, version 8)↗[Public]
FDA Leqembi — Leqembi / Leqembi Iqlik (lecanemab-irmb) — Prescribing Information (SPL effective 2026-07-21, version 24)↗[Public]
FDA Neupro — Neupro (rotigotine transdermal system) — Prescribing Information (SPL effective 2026-09-10, version 22)↗[Public]
FDA Apokyn — Apokyn (apomorphine hydrochloride) injection 10 mg/mL — Prescribing Information (SPL effective 2024-10-10, version 21)↗[Public]
FDA Selegiline caps — Selegiline hydrochloride capsules 5 mg — Prescribing Information (SPL effective 2026-09-17, version 9)↗[Public]
FDA Benztropine tabs — Benztropine mesylate tablets USP — Prescribing Information (SPL effective 2026-08-20, version 11)↗[Public]
FDA Botox — Botox (onabotulinumtoxinA) for injection — Prescribing Information (SPL effective 2023-11-18, version 62)↗[Public]
FDA Zolmitriptan — Zolmitriptan tablets 2.5/5 mg — Prescribing Information (SPL effective 2026-04-16, version 7)↗[Public]
FDA Relpax — Relpax (eletriptan) tablets — Prescribing Information (SPL effective 2024-01-15, version 4)↗[Public]
FDA Naratriptan — Naratriptan tablets 1/2.5 mg — Prescribing Information (SPL effective 2026-06-30, version 4)↗[Public]
FDA Frovatriptan — Frovatriptan succinate tablets 2.5 mg — Prescribing Information (SPL effective 2026-06-27, version 2)↗[Public]
FDA Reyvow — Reyvow (lasmiditan) tablets — Prescribing Information (SPL effective 2026-01-08, version 16)↗[Public]
FDA Qulipta — Qulipta (atogepant) tablets — Prescribing Information (SPL effective 2025-09-30, version 19)↗[Public]
FDA Ajovy — Ajovy (fremanezumab-vfrm) injection — Prescribing Information (SPL effective 2026-06-05, version 24)↗[Public]
FDA Vyepti — Vyepti (eptinezumab-jjmr) injection — Prescribing Information (SPL effective 2026-06-05, version 32)↗[Public]
FDA Viibryd — Viibryd (vilazodone) tablets — Prescribing Information (SPL effective 2023-10-01, version 34)↗[Public]
FDA Fetzima — Fetzima (levomilnacipran) extended-release capsules — Prescribing Information (SPL effective 2024-04-30, version 33)↗[Public]
FDA Savella — Savella (milnacipran) tablets — Prescribing Information (SPL effective 2025-09-10, version 41)↗[Public]
FDA Nefazodone — Nefazodone hydrochloride tablets USP (Teva) — Prescribing Information (SPL effective 2025-07-31, version 12)↗[Public]
FDA Nardil — Nardil (phenelzine sulfate) tablets 15 mg — Prescribing Information (SPL effective 2025-06-06, version 11)↗[Public]
FDA Tranylcypromine — Tranylcypromine sulfate tablets 10 mg — Prescribing Information (SPL effective 2025-07-25, version 8)↗[Public]
FDA Lunesta — Lunesta (eszopiclone) tablets — Prescribing Information (SPL effective 2025-01-08, version 2)↗[Public]
FDA Zaleplon — Zaleplon capsules USP 5/10 mg — Prescribing Information (SPL effective 2019-08-26, version 11)↗[Public]
FDA Rozerem — Rozerem (ramelteon) tablets 8 mg — Prescribing Information (SPL effective 2026-04-15, version 20)↗[Public]
FDA Dayvigo — Dayvigo (lemborexant) tablets — Prescribing Information (SPL effective 2025-02-24, version 39)↗[Public]
FDA Quviviq — Quviviq (daridorexant) tablets — Prescribing Information (SPL effective 2026-02-26, version 13)↗[Public]
FDA Qelbree — Qelbree (viloxazine extended-release capsules) — Prescribing Information (SPL effective 2026-10-05, version 16)↗[Public]
FDA Focalin — Focalin (dexmethylphenidate hydrochloride) tablets — Prescribing Information (SPL effective 2024-05-30, version 2)↗[Public]
FDA Epidiolex — Epidiolex (cannabidiol) oral solution 100 mg/mL — Prescribing Information (SPL effective 2026-05-29, version 35)↗[Public]
FDA Dexilant — Dexilant (dexlansoprazole) delayed-release capsules — Prescribing Information (SPL effective 2025-02-17, version 40)↗[Public]
FDA Amitiza — Amitiza (lubiprostone) capsules — Prescribing Information (SPL effective 2026-07-10, version 4)↗[Public]
FDA Trulance — Trulance (plecanatide) tablets 3 mg — Prescribing Information (SPL effective 2024-04-04, version 15)↗[Public]
FDA Alosetron — Alosetron tablets 0.5/1 mg — Prescribing Information (SPL effective 2025-10-03, version 3)↗[Public]
FDA Viberzi — Viberzi (eluxadoline) tablets — Prescribing Information (SPL effective 2024-07-16, version 28)↗[Public]
FDA Entyvio — Entyvio (vedolizumab) for injection and subcutaneous injection — Prescribing Information (SPL effective 2026-04-29, version 26)↗[Public]
FDA Emend — Emend (aprepitant) capsules and oral suspension — Prescribing Information (SPL effective 2024-07-05, version 42)↗[Public]
FDA Fosaprepitant — Fosaprepitant for injection 150 mg — Prescribing Information (SPL effective 2026-10-06, version 8)↗[Public]
FDA Palonosetron — Palonosetron hydrochloride injection 0.25 mg/5 mL — Prescribing Information (SPL effective 2026-08-25, version 8)↗[Public]
FDA Marinol — Marinol (dronabinol) capsules — Prescribing Information (SPL effective 2023-02-14, version 5)↗[Public]
FDA Incruse Ellipta — Incruse Ellipta (umeclidinium) inhalation powder — Prescribing Information (SPL effective 2023-12-13, version 27)↗[Public]
FDA Tudorza Pressair — Tudorza Pressair (aclidinium bromide) inhalation powder — Prescribing Information (SPL effective 2022-08-01, version 2)↗[Public]
FDA Striverdi Respimat — Striverdi Respimat (olodaterol) inhalation spray — Prescribing Information (SPL effective 2025-01-03, version 9)↗[Public]
FDA Breo Ellipta — Breo Ellipta (fluticasone furoate/vilanterol) inhalation powder — Prescribing Information (SPL effective 2024-11-07, version 29)↗[Public]
FDA Nucala — Nucala (mepolizumab) for injection and injection — Prescribing Information (SPL effective 2025-08-06, version 24)↗[Public]
FDA Fasenra — Fasenra (benralizumab) injection — Prescribing Information (SPL effective 2026-05-13, version 27)↗[Public]
FDA Tezspire — Tezspire (tezepelumab-ekko) injection — Prescribing Information (SPL effective 2025-10-17, version 16)↗[Public]
FDA Zafirlukast — Zafirlukast tablets 10/20 mg — Prescribing Information (SPL effective 2026-03-16, version 7)↗[Public]
FDA Pulmozyme — Pulmozyme (dornase alfa) inhalation solution — Prescribing Information (SPL effective 2025-12-17, version 24)↗[Public]
FDA Glycopyrrolate inj — Glycopyrrolate injection USP 0.2 mg/mL (American Regent) — Prescribing Information (SPL effective 2024-02-07, version 12)↗[Public]
FDA Probenecid — Probenecid tablets USP 500 mg — Prescribing Information (SPL effective 2026-01-28, version 5)↗[Public]
FDA Krystexxa — Krystexxa (pegloticase) injection — Prescribing Information (SPL effective 2026-07-09, version 1149)↗[Public]
FDA Benlysta — Benlysta (belimumab) for injection and injection — Prescribing Information (SPL effective 2026-08-21, version 38)↗[Public]
FDA Kineret — Kineret (anakinra) injection — Prescribing Information (SPL effective 2026-04-03, version 24)↗[Public]
FDA Actemra — Actemra (tocilizumab) injection — Prescribing Information (SPL effective 2025-12-16, version 53)↗[Public]
FDA Orencia — Orencia (abatacept) for injection and injection — Prescribing Information (SPL effective 2025-11-13, version 35)↗[Public]
FDA Cimzia — Cimzia (certolizumab pegol) — Prescribing Information (SPL effective 2026-02-24, version 47)↗[Public]
FDA Simponi — Simponi (golimumab) injection — Prescribing Information (SPL effective 2026-09-17, version 43)↗[Public]
FDA Taltz — Taltz (ixekizumab) injection — Prescribing Information (SPL effective 2026-01-22, version 40)↗[Public]
FDA Tremfya — Tremfya (guselkumab) injection — Prescribing Information (SPL effective 2026-06-04, version 29)↗[Public]
FDA Skyrizi — Skyrizi (risankizumab-rzaa) — Prescribing Information (SPL effective 2026-06-15, version 179)↗[Public]
FDA Ilumya — Ilumya (tildrakizumab-asmn) injection — Prescribing Information (SPL effective 2026-10-05, version 20)↗[Public]
FDA Tysabri — Tysabri (natalizumab) injection — Prescribing Information (SPL effective 2025-03-21, version 47)↗[Public]
FDA Ocrevus — Ocrevus (ocrelizumab) injection for IV use — Prescribing Information (SPL effective 2026-05-14, version 24)↗[Public]
FDA Kesimpta — Kesimpta (ofatumumab) injection — Prescribing Information (SPL effective 2026-04-01, version 11)↗[Public]
FDA Mavenclad — Mavenclad (cladribine) tablets 10 mg — Prescribing Information (SPL effective 2026-05-27, version 10)↗[Public]
FDA Mayzent — Mayzent (siponimod) tablets — Prescribing Information (SPL effective 2026-06-30, version 17)↗[Public]
FDA Zeposia — Zeposia (ozanimod) capsules — Prescribing Information (SPL effective 2026-04-16, version 25)↗[Public]
FDA Copaxone — Copaxone (glatiramer acetate) injection — Prescribing Information (SPL effective 2026-06-23, version 36)↗[Public]
FDA Avonex — Avonex (interferon beta-1a) injection for IM use — Prescribing Information (SPL effective 2025-11-19, version 23)↗[Public]
FDA Alfuzosin ER — Alfuzosin HCl extended-release tablets 10 mg (Apotex) — Prescribing Information (SPL effective 2026-09-03, version 18)↗[Public]
FDA Silodosin — Silodosin capsules 4/8 mg — Prescribing Information (SPL effective 2026-08-18, version 3)↗[Public]
FDA Darifenacin ER — Darifenacin extended-release tablets 7.5/15 mg — Prescribing Information (SPL effective 2026-02-10, version 10)↗[Public]
FDA Trospium — Trospium chloride tablets 20 mg — Prescribing Information (SPL effective 2026-09-03, version 14)↗[Public]
FDA Gemtesa — Gemtesa (vibegron) tablets 75 mg — Prescribing Information (SPL effective 2025-04-01, version 12)↗[Public]
FDA Acitretin — Acitretin capsules USP 10/17.5/25 mg — Prescribing Information (SPL effective 2026-08-05, version 8)↗[Public]
FDA Tazorac cream — Tazorac (tazarotene) cream 0.05%/0.1% — Prescribing Information (SPL effective 2025-11-13, version 6)↗[Public]
FDA Jublia — Jublia (efinaconazole) topical solution 10% — Prescribing Information (SPL effective 2025-07-01, version 21)↗[Public]
FDA Tavaborole — Tavaborole topical solution 5% — Prescribing Information (SPL effective 2025-09-15, version 7)↗[Public]
FDA Lumigan 0.01% — Lumigan (bimatoprost ophthalmic solution) 0.01% — Prescribing Information (SPL effective 2024-06-22, version 19)↗[Public]
FDA Travatan Z — Travatan Z (travoprost ophthalmic solution) 0.004% — Prescribing Information (SPL effective 2023-06-27, version 6)↗[Public]
FDA Pilocarpine 1.25% — Pilocarpine HCl ophthalmic solution 1.25% — Prescribing Information (SPL effective 2025-06-02, version 6)↗[Public]
FDA Xiidra — Xiidra (lifitegrast ophthalmic solution) 5% — Prescribing Information (SPL effective 2025-08-18, version 6)↗[Public]
FDA Lucentis — Lucentis (ranibizumab) intravitreal injection — Prescribing Information (SPL effective 2025-11-21, version 27)↗[Public]
FDA Eylea — Eylea (aflibercept) intravitreal injection 2 mg — Prescribing Information (SPL effective 2026-07-07, version 41)↗[Public]

UK SmPC (eMC / MHRA)

UK SmPC Metoclopramide — Metoclopramide hydrochloride 5 mg/5 ml Oral Solution — Summary of Product Characteristics (Revised 26/01/2026)↗[Public]
UK SmPC Domperidone — Domperidone 1 mg/ml Oral Suspension — Summary of Product Characteristics (Revised 04/11/2025)↗[Public]
UK SmPC Neoclarityn — NeoClarityn (desloratadine) 0.5 mg/ml Oral Solution — Summary of Product Characteristics (Revised 01 January 2021)↗[Public]
UK SmPC Piriton — Piriton Syrup (chlorphenamine maleate 2 mg/5 ml) — Summary of Product Characteristics (Revised 14 April 2023)↗[Public]
UK SmPC Sytron — Sytron 27.5 mg iron per 5 ml Oral Solution (sodium feredetate) — Summary of Product Characteristics (Revised 01/05/2025)↗[Public]
UK SmPC Thorens D3 — THORENS 10 000 I.U./ml oral drops (colecalciferol) — Summary of Product Characteristics (Revised 13 January 2022)↗[Public]
UK SmPC Prednisolone — Prednisolone 10 mg/ml Oral Solution — Summary of Product Characteristics (Revised 11/2025)↗[Public]
UK SmPC Movicol Paed — MOVICOL Paediatric Chocolate flavour 6.8 g powder for oral solution — Summary of Product Characteristics (Revised 11/03/2025)↗[Public]
UK SmPC Budesonide neb — Budesonide 0.5 mg nebuliser suspension — Summary of Product Characteristics (Revised 14/05/2024)↗[Public]
UK SmPC Diamicron 80 — Diamicron 80 mg Tablets — Summary of Product Characteristics (Revised 02/2020)↗[Public]
UK SmPC Gliclazide MR 30 — Gliclazide Krka 30 mg modified-release tablets — Summary of Product Characteristics (Revised 24/10/2023)↗[Public]
UK SmPC Serc 8 — Serc-8 (betahistine dihydrochloride 8 mg) tablets — Summary of Product Characteristics (Revised November 2025)↗[Public]
UK SmPC Buscopan — Buscopan 10 mg Tablets — Summary of Product Characteristics (Revised 22/09/2025)↗[Public]
UK SmPC Colofac — Colofac (mebeverine) 135 mg Coated Tablets — Summary of Product Characteristics (Revised Jun 2025)↗[Public]
UK SmPC Fucidin cream — Fucidin 20 mg/g Cream — Summary of Product Characteristics (Revised 01 June 2026)↗[Public]
UK SmPC Canesten cream — Canesten (clotrimazole 1%) Cream — Summary of Product Characteristics (Revised 07/06/2022)↗[Public]
UK SmPC Canesten pess. — Canesten Thrush Pessary 500 mg — Summary of Product Characteristics (Revised 06/06/2023)↗[Public]
UK SmPC Folic acid 5 mg — Folic Acid Tablets 5 mg — Summary of Product Characteristics (Revised 20/05/2026)↗[Public]
UK SmPC Ferrous sulfate — Ferrous Sulfate Tablets 200 mg — Summary of Product Characteristics (Revised 01/09/2021)↗[Public]
UK SmPC Hydroxocobalamin — Hydroxocobalamin 1 mg/ml Solution for Injection — Summary of Product Characteristics (Revised 23/01/2024)↗[Public]
UK SmPC Adcal-D3 — Adcal-D3 chewable tablets — Summary of Product Characteristics (Revised 04/2025)↗[Public]
UK SmPC Indapamide — Indapamide 2.5 mg Tablets — Summary of Product Characteristics (Revised 02/04/2026)↗[Public]
UK SmPC Voltarol amp. — Voltarol Ampoules (diclofenac sodium 75 mg/3 mL) — Summary of Product Characteristics (Revised 9 September 2025)↗[Public]
UK SmPC Buscopan amp. — Buscopan Ampoules (hyoscine butylbromide 20 mg/mL) — Summary of Product Characteristics (Revised 11/12/2025)↗[Public]
UK SmPC Metronidazole — Metronidazole 200 mg/5 ml Oral Suspension — Summary of Product Characteristics (Revised 20/06/2023)↗[Public]
UK SmPC Betnesol drops — Betnesol Eye, Ear and Nose Drops 0.1% — Summary of Product Characteristics (Revised 11/01/2021)↗[Public]
UK SmPC Chloramphenicol — Minims Chloramphenicol 0.5% eye drops — Summary of Product Characteristics (Revised see eMC)↗[Public]
UK SmPC Fucidin H — Fucidin H cream (fusidic acid 2% + hydrocortisone 1%) — Summary of Product Characteristics (Revised see eMC)↗[Public]
UK SmPC Fortacin — Fortacin 150 mg/ml + 50 mg/ml cutaneous spray (lidocaine/prilocaine) — Summary of Product Characteristics (Revised 14 November 2024)↗[Public]
UK SmPC Otrivine 0.1% — Otrivine Blocked Nose Relief 0.1% w/v nasal spray (xylometazoline) — Summary of Product Characteristics (Revised 27 February 2024)↗[Public]
UK SmPC Difflam rinse — Difflam 0.15% w/v Sore Throat Rinse (benzydamine) — Summary of Product Characteristics (Revised September 2025)↗[Public]
UK SmPC Stugeron 15mg — Stugeron 15 mg tablets (cinnarizine) — Summary of Product Characteristics (Revised 19 December 2022)↗[Public]
UK SmPC Phenobarb elixir — Phenobarbital Elixir BP 15 mg/5 mL — Summary of Product Characteristics (Revised 12 November 2021)↗[Public]
UK SmPC Daktarin gel — Daktarin Oral Gel (miconazole 20 mg/g) — Summary of Product Characteristics (Revised 27 August 2026)↗[Public]
UK SmPC Ilaxten 20mg — Ilaxten 20 mg tablets (bilastine) — Summary of Product Characteristics (Revised 11 February 2026)↗[Public]
UK Dostinex SmPC — Dostinex (cabergoline) tablets — SmPC (Revised 09/2024)↗[Public]
UK Dienogest 2 mg SmPC — Dienogest 2 mg tablets — SmPC (Revised 05/08/2024)↗[Public]
UK Galvus SmPC — Galvus 50 mg tablets (vildagliptin) — SmPC (Revised 22 June 2023)↗[Public]
eMC Arcoxia — Arcoxia (etoricoxib) 30/60/90/120 mg film-coated tablets — SmPC (Revised 19 March 2025)↗[Public]
eMC Circadin — Circadin (melatonin) 2 mg prolonged-release tablets — SmPC (Revised 1 January 2021)↗[Public]
eMC Typhim Vi — Typhim Vi (typhoid Vi polysaccharide vaccine) — SmPC (Revised 4 January 2025)↗[Public]
eMC Synagis — Synagis (palivizumab) 50 mg/0.5 mL and 100 mg/1 mL — SmPC (Revised 26 March 2024)↗[Public]
eMC Valdoxan — Valdoxan (agomelatine) 25 mg film-coated tablets — SmPC (Revised 15 April 2026)↗[Public]

EU SmPC (EMA)

EMA Priligy leaflet — Priligy (dapoxetine) — EMA Article 29 referral, Annex III: labelling and package leaflet↗[Public]

Published guideline

FDA DSC 2018 — FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older (Safety Announcement 2018-01-11)↗[Public]
CPS AOM 2016 — Management of acute otitis media in children six months of age and older. Le Saux N, Robinson JL. Paediatr Child Health 2016;21(1):39-44 (Reaffirmed 2024-11-21)↗[Public]
CPS Ondansetron 2018 — Emergency department use of oral ondansetron for acute gastroenteritis-related vomiting in infants and children. Cheng A; updated by Doré-Bergeron MJ, Chauvin-Kimoff L. Practice point, posted 2018-12-19↗[Public]
CPS Croup — Acute management of croup in the emergency department. Ortiz-Alvarez O. Practice point; posted 2017-05-24, updated 2026-03-06↗[Public]
WHO/USAID Diarrhoea 2005 — Diarrhoea Treatment Guidelines including new recommendations for the use of ORS and zinc supplementation for clinic-based healthcare workers (January 2005)↗[Public]
WHO eLENA Zinc — Zinc supplementation in the management of diarrhoea (WHO e-Library of Evidence for Nutrition Actions) (Last updated 2023-08-09)↗[Public]
WHO Fact sheet — Diarrhoeal disease — WHO fact sheet (7 March 2024)↗[Public]

Licensed reference (medical school)

Licensed ref — Licensed pediatric dosing reference (pending, via medical school license)[License pending]

Iranian leaflet (IFDA)

No sources of this type recorded yet.

Reference textbook

No sources of this type recorded yet.

MedlinePlus (U.S. National Library of Medicine)

MedlinePlus — MedlinePlus Medical Encyclopedia: Ear infection - acute (Review date 2025-01-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Strep throat (Review date 2025-07-03)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Community-acquired pneumonia in adults (Review date 2024-08-19)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Sinusitis (Review date 2026-04-29)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Allergic rhinitis (Review date 2026-01-20)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Constipation in infants and children (Review date 2024-07-31)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Autism spectrum disorder (Review date 2025-04-06)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Schizophrenia (Review date 2024-07-17)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Bipolar disorder (Review date 2024-07-17)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Juvenile idiopathic arthritis (Review date 2025-04-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Cellulitis (Review date 2025-04-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Impetigo (Review date 2024-10-13)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Osteomyelitis (Review date 2026-03-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Urinary tract infection - children (Review date 2026-01-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Gonorrhea (Review date 2025-05-22)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Pertussis (Review date 2025-07-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Shigellosis (Review date 2026-03-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Pneumocystis jirovecii pneumonia (Review date 2025-12-13)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Amebiasis (Review date 2024-08-29)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Peptic ulcer (Review date 2025-04-21)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Gastroesophageal reflux disease - children (Review date 2024-07-31)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Giardia infection (Review date 2026-03-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Cryptosporidium enteritis (Review date 2026-03-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Viral gastroenteritis (stomach flu) (Review date 2026-04-27)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Generalized anxiety disorder (Review date 2025-04-19)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Hives (Review date 2025-04-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Asthma in children (Review date 2025-04-06)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Thrush - children and adults (Review date 2025-08-05)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Irritable bowel syndrome (Review date 2025-04-21)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Amebic liver abscess (Review date 2025-05-12)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Acute bronchitis (Review date 2026-02-27)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Flu (Review date 2024-07-23)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Chickenpox (Review date 2025-07-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Scabies (Review date 2025-11-20)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Pinworms (Review date 2024-10-09)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Ascariasis (Review date 2024-11-10)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Hookworm infection (Review date 2025-08-05)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Whipworm infection (Review date 2024-11-10)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Cysticercosis (Review date 2025-12-13)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Iron deficiency anemia (Review date 2025-04-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Rickets (Review date 2024-07-16)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Croup (Review date 2026-01-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Type 2 diabetes (Review date 2025-01-10)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Hypothyroidism (Review date 2024-07-21)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Osteoarthritis (Review date 2026-04-09)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Rheumatoid arthritis (Review date 2025-01-28)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Attention deficit hyperactivity disorder (Review date 2026-05-15)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Major depression (Review date 2025-04-19)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Obsessive-compulsive disorder (Review date 2026-05-15)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Panic disorder (Review date 2026-05-15)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Post-traumatic stress disorder (Review date 2026-05-15)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Social anxiety disorder (Review date 2026-05-15)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Bulimia (Review date 2026-05-15)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Tourette syndrome (Review date 2026-01-27)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Epilepsy (Review date 2025-04-16)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Migraine (Review date 2025-02-11)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Generalized anxiety disorder (Review date 2025-04-19)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Seasonal affective disorder (Review date 2026-05-15)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Trigeminal neuralgia (Review date 2026-05-04)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Psychosis (Review date 2026-05-15)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Essential tremor (Review date 2026-05-04)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Conjunctivitis or pink eye (Review date 2024-07-09)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Allergic conjunctivitis (Review date 2024-07-22)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Common cold (Review date 2025-01-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Heart failure (Review date 2024-07-14)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Atrial fibrillation and atrial flutter (Review date 2025-01-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Hyperthyroidism (Review date 2024-07-21)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Type 1 diabetes (Review date 2025-01-10)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Vaginal yeast infection (Review date 2025-08-18)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Fungal nail infection (Review date 2024-10-13)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Herpes - oral (Review date 2025-07-03)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Genital herpes (Review date 2025-07-03)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Shingles (Review date 2024-11-10)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Syphilis (Review date 2024-08-29)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Meningitis (Review date 2024-11-10)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Typhoid fever (Review date 2025-05-12)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Gout (Review date 2025-04-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Fibromyalgia (Review date 2025-01-28)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Insomnia (Review date 2026-05-15)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Meniere disease (Review date 2025-07-17)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Enlarged prostate (Review date 2025-07-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Urge incontinence (Review date 2025-07-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Chronic obstructive pulmonary disease (COPD) (Review date 2025-04-10)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Ringworm of the body (Review date 2024-10-13)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Tinea versicolor (Review date 2024-10-14)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Seborrheic dermatitis (Review date 2025-04-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Burns (Review date 2026-04-09)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Absent menstrual periods - secondary (Review date 2026-05-29)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Abnormal uterine bleeding (Review date 2024-10-15)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Osteoporosis (Review date 2025-01-28)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Deep vein thrombosis (Review date 2025-04-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Swimmer's ear (Review date 2024-07-16)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Trichomoniasis (Review date 2024-11-10)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Ringworm of the scalp (Review date 2024-10-13)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Helicobacter pylori infection (Review date 2026-01-13)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Alzheimer disease (Review date 2026-01-27)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Parkinson disease (Review date 2026-01-27)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Restless legs syndrome (Review date 2025-07-17)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Erection problems (Review date 2025-10-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Endometriosis (Review date 2025-05-22)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Acne (Review date 2025-08-02)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Psoriasis (Review date 2024-08-05)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Ear wax (Review date 2026-04-29)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Anaphylaxis (Review date 2026-01-20)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Septic shock (Review date 2025-12-13)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Cardiogenic shock (Review date 2026-06-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Stroke (Review date 2025-04-16)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Pulmonary embolus (Review date 2025-10-21)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Metabolic acidosis (Review date 2025-10-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Low blood potassium (Review date 2025-05-19)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Low blood sodium (Review date 2025-05-19)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Brucellosis (Review date 2025-08-05)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Low back pain - acute (Review date 2026-06-27)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Sprains (Review date 2025-04-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Tendinitis (Review date 2024-07-23)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Tension headache (Review date 2025-10-27)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Measles (Review date 2024-07-16)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Hemorrhoids (Review date 2025-07-22)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Anal fissure (Review date 2026-04-11)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Blepharitis (Review date 2024-08-05)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Vitiligo (Review date 2026-04-09)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Molluscum contagiosum (Review date 2025-04-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Acromegaly (Review date 2025-04-24)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Carcinoid syndrome (Review date 2024-07-29)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Peritonitis - secondary (Review date 2026-04-27)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Hospital-acquired pneumonia (Review date 2025-07-25)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Bipolar disorder (Review date 2024-07-17)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Schizoaffective disorder (Review date 2026-05-15)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Neurogenic bladder (Review date 2026-05-04)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Plague (Review date 2025-05-12)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Chancroid (Review date 2025-08-05)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Lymphogranuloma venereum (Review date 2025-08-05)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Donovanosis (granuloma inguinale) (Review date 2025-08-05)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Pubic lice (Review date 2024-10-13)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Genital warts (Review date 2024-10-15)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Black widow spider (Review date 2025-07-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Brown recluse spider (Review date 2025-07-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Scorpions (Review date 2025-07-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Snake bites (Review date 2025-10-14)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Mucormycosis (Review date 2024-11-10)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Amyotrophic lateral sclerosis (ALS) (Review date 2026-05-04)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Huntington disease (Review date 2025-04-16)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Tardive dyskinesia (Review date 2026-05-04)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Duchenne muscular dystrophy (Review date 2025-10-27)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Multiple sclerosis (Review date 2026-01-27)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Lambert-Eaton myasthenic syndrome (Review date 2026-05-04)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Hypokalemic periodic paralysis (Review date 2025-10-23)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Psoriatic arthritis (Review date 2025-01-28)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Transplant rejection (Review date 2025-04-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Non-Hodgkin lymphoma (Review date 2025-02-03)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Pemphigus vulgaris (Review date 2026-04-09)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Prostate cancer (Review date 2025-07-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Chronic myelogenous leukemia (CML) (Review date 2026-01-29)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Colorectal cancer (Review date 2025-04-01)↗[Public]
MedlinePlus — MedlinePlus Medical Encyclopedia: Narcolepsy (Review date 2025-07-17)↗[Public]

Pharmacy website (secondary, unreliable)

Salamati24 Corizan — کوریزان کودکان سرماخوردگی و آنفلوانزا — صفحه دارو↗[Public]
Adorateb Corizan — شربت کوریزان سرماخوردگی و آنفولانزا — صفحه محصول↗[Public]
Darooyab Ketotifen — کتوتیفن — موارد مصرف، دوز، اشکال دارویی↗[Public]
Darooyab Theophylline G — تئوفیلین جی — دارویاب↗[Public]
Beytoote Bromhexine — کاربردهای شربت برم هگزین و عوارض و دوز مصرفی آن↗[Public]
Darooyab Biperiden — بی‌پریدن — موارد مصرف، اشکال دارویی، نام‌های تجاری↗[Public]
Darooyab Dydrogesterone — دیدروژسترون — موارد مصرف، اشکال دارویی، نام‌های تجاری↗[Public]
Darooyab Aluminium MGS — آلومینیوم ام جی اس — موارد مصرف، اشکال دارویی↗[Public]
Darooyab Vitamin A+D — ویتامین آ + د خوراکی — موارد مصرف، اشکال دارویی↗[Public]
Darooyab Eternavit AD — قطره آ د اترنیویت ۳۰ میلی‌لیتر↗[Public]
Darooyab B Complex — ویتامین ب کمپلکس — موارد مصرف، اشکال دارویی↗[Public]
Darooyab Contracep. HD — کنتراسپتیو اچ دی — موارد مصرف، اشکال دارویی↗[Public]
Darooyab Aburaihan — داروسازی ابوریحان — فهرست فرآورده‌ها (شیاف ایبوپروفن)↗[Public]
Darooyab — Darooyab — Iranian generic drug pages (IFDA generic codes, registered dosage forms and brands)↗[Public]
Darooyab Trimetazidine — تری‌متازیدین — موارد مصرف و اشکال دارویی↗[Public]
Darooyab Flunarizine — فلوناریزین — موارد مصرف، منع مصرف و اشکال دارویی↗[Public]
Darooyab Cloxacillin — کلوگزاسیلین — موارد مصرف، مصرف در بارداری و اشکال دارویی↗[Public]
Darooyab Penicillin 633 — پنی‌سیلین ۶.۳.۳ — موارد مصرف، منع مصرف و اشکال دارویی↗[Public]
Darooyab Adult cold — سرماخوردگی بزرگسالان — موارد مصرف، ترکیب‌ها و اشکال دارویی↗[Public]
Darooyab Antihist-Decong — آنتی‌هیستامین دکونژستانت — موارد مصرف و اشکال دارویی↗[Public]
Darooyab Albendazole — آلبندازول — اشکال دارویی (سوسپانسیون ۴۰۰ mg/۱۰ mL)↗[Public]
Darooyab Furazolidone — فورازولیدون — موارد مصرف، منع مصرف، تداخلات و اشکال دارویی↗[Public]
Darooyab Glucantime — مگلومین آنتی موان — موارد مصرف، منع مصرف و اشکال دارویی↗[Public]
Darooyab Antiscorpion — ضدسم عقرب — موارد مصرف، هشدارها و اشکال دارویی↗[Public]
Darooyab Antisnake — ضدسم مار — موارد مصرف، هشدارها و اشکال دارویی↗[Public]
Darooyab Streptokinase — استرپتوکیناز — موارد مصرف، منع مصرف و اشکال دارویی↗[Public]